<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006482.pub4" GROUP_ID="ARI" ID="941306110902513076" MERGED_FROM="" MODIFIED="2014-10-22 23:11:56 +0100" MODIFIED_BY="Liz Dooley" REVIEW_NO="A136" REVMAN_SUB_VERSION="5.3.4 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="9.0">
<COVER_SHEET MODIFIED="2014-10-22 23:11:56 +0100" MODIFIED_BY="Liz Dooley">
<TITLE>Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia</TITLE>
<CONTACT MODIFIED="2014-10-22 23:11:56 +0100" MODIFIED_BY="Liz Dooley"><PERSON ID="3F61829582E26AA20178986BB7D20855" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Paulo José Zimermann</FIRST_NAME><LAST_NAME>Teixeira</LAST_NAME><SUFFIX>MD PhD</SUFFIX><POSITION>Adjunct Professor</POSITION><EMAIL_1>paulozt@via-rs.net</EMAIL_1><EMAIL_2>paulozt@ufcspa.edu.br</EMAIL_2><ADDRESS><DEPARTMENT>Department of Pulmonary Medicine - Pavilhão Pereira Filho - Santa Casa de Porto Alegre</DEPARTMENT><ORGANISATION>Federal University of Health Sciences of Porto Alegre (UFCSPA) and Feevale University</ORGANISATION><ADDRESS_1>Rua Prof Annes Dias, 295</ADDRESS_1><CITY>Porto Alegre</CITY><ZIP>CEP 90020-090</ZIP><REGION>Rio Grande do Sul</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 51 3228 9835</PHONE_1><FAX_1>+55 51 3228 9835</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2014-10-22 23:11:56 +0100" MODIFIED_BY="Liz Dooley"><PERSON ID="3F5AEEAF82E26AA20178986B12136E28" ROLE="AUTHOR"><FIRST_NAME>Danilo Cortozi</FIRST_NAME><LAST_NAME>Berton</LAST_NAME><SUFFIX>MD</SUFFIX><POSITION>Pulmonologist</POSITION><EMAIL_1>dcberton@gmail.com</EMAIL_1><MOBILE_PHONE>+55 51 99771150</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Pulmonary Medicine - Pavilhão Pereira Filho - Santa Casa de Porto Alegre</DEPARTMENT><ORGANISATION>Federal University of Health Sciences of Porto Alegre (UFCSPA) and Feevale University</ORGANISATION><ADDRESS_1>Rua Prof Annes Dias, 295</ADDRESS_1><CITY>Porto Alegre</CITY><ZIP>CEP 90020-090</ZIP><REGION>Rio Grande do Sul</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 51 3228 9835</PHONE_1><FAX_1>+55 51 3228 9835</FAX_1></ADDRESS></PERSON><PERSON ID="30DC353582E26AA201BA4B54C38C56F8" ROLE="AUTHOR"><FIRST_NAME>Andre</FIRST_NAME><MIDDLE_INITIALS>C</MIDDLE_INITIALS><LAST_NAME>Kalil</LAST_NAME><SUFFIX>MD</SUFFIX><POSITION>Professor of Medicine</POSITION><EMAIL_1>akalil@unmc.edu</EMAIL_1><ADDRESS><DEPARTMENT>Department of Internal Medicine</DEPARTMENT><ORGANISATION>Infectious Diseases Division, University of Nebraska Medical Center</ORGANISATION><CITY>Omaha</CITY><ZIP>985400</ZIP><REGION>Nebraska</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 402 559 8650</PHONE_1><FAX_1>+1 402 559 5581</FAX_1></ADDRESS></PERSON><PERSON ID="3F61829582E26AA20178986BB7D20855" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Paulo José Zimermann</FIRST_NAME><LAST_NAME>Teixeira</LAST_NAME><SUFFIX>MD PhD</SUFFIX><POSITION>Adjunct Professor</POSITION><EMAIL_1>paulozt@via-rs.net</EMAIL_1><EMAIL_2>paulozt@ufcspa.edu.br</EMAIL_2><ADDRESS><DEPARTMENT>Department of Pulmonary Medicine - Pavilhão Pereira Filho - Santa Casa de Porto Alegre</DEPARTMENT><ORGANISATION>Federal University of Health Sciences of Porto Alegre (UFCSPA) and Feevale University</ORGANISATION><ADDRESS_1>Rua Prof Annes Dias, 295</ADDRESS_1><CITY>Porto Alegre</CITY><ZIP>CEP 90020-090</ZIP><REGION>Rio Grande do Sul</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 51 3228 9835</PHONE_1><FAX_1>+55 51 3228 9835</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2014-10-23 06:40:51 +1000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="21" MONTH="10" YEAR="2014"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="21" MONTH="10" YEAR="2014"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="21" MONTH="10" YEAR="2016"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2008"/>
<LAST_CITATION_ISSUE ISSUE="10" YEAR="2014"/>
</DATES>
<WHATS_NEW MODIFIED="2014-10-23 06:41:47 +1000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-10-23 06:41:08 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="21" MONTH="10" YEAR="2014"/>
<DESCRIPTION>
<P>Searches updated but we did not identify any new trials for inclusion or exclusion.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-07-16 14:05:01 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="17" MONTH="2" YEAR="2014"/>
<DESCRIPTION>
<P>Our conclusions remain unchanged.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2014-07-16 14:03:52 +1000" MODIFIED_BY="Liz Dooley">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-07-16 14:03:52 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="23" MONTH="6" YEAR="2011"/>
<DESCRIPTION>
<P>Our conclusions remain unchanged.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-07-16 14:03:47 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="23" MONTH="6" YEAR="2011"/>
<DESCRIPTION>
<P>Searches were updated but no new trials were included in this update. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-08-05 10:32:51 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="18" MONTH="2" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-10-23 06:46:13 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2014-10-23 06:42:38 +1000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2014-08-13 07:23:13 +1000" MODIFIED_BY="[Empty name]">Quantitative versus qualitative cultures of respiratory secretions in patients with ventilator-associated pneumonia</TITLE>
<SUMMARY_BODY MODIFIED="2014-10-23 06:42:38 +1000" MODIFIED_BY="[Empty name]">
<P>
<B>Review question</B>
<BR/>We wanted to determine whether quantitative cultures of respiratory secretions are effective in reducing mortality in immunocompetent patients with ventilator-associated pneumonia compared with qualitative cultures. We also evaluated changes in antibiotic use, length of intensive care unit (ICU) stay and mechanical ventilation.<BR/>
<BR/>
<B>Background</B>
<BR/>Ventilator-associated pneumonia (VAP) is a condition which occurs in patients mechanically ventilated for more than 48 hours, which can significantly increase the mortality of ICU patients. The best method for diagnosing VAP and identifying the causative organism (bacteria) is uncertain. Both invasive and non-invasive techniques are used to obtain samples of respiratory secretions and these can be analysed quantitatively (with a threshold count of the bacterial growth to differentiate between infection and colonisation of the lower airways) or qualitatively (presence or absence of pathogenic germs in the culture). The rationale for using quantitative cultures of respiratory secretions sampled from patients with VAP is to differentiate the infectious organisms (those with a higher concentration) from colonising organisms (those with lower concentration), thereby optimising antibiotic therapy.<BR/>
</P>
<P>
<B>Study characteristics</B>
<BR/>After reviewing 5064 articles we found three randomised controlled trials (RCTs) (1240 participants) comparing invasive methods using quantitative cultures, versus the non-invasive method using qualitative cultures. Two additional RCTs (127 participants) compared invasive versus non-invasive methods, both using quantitative cultures. We combined all five RCTs (1367 participants) to compare invasive versus non-invasive interventions for diagnosing VAP.</P>
<P>
<B>Key results</B>
<BR/>The cumulative all-cause mortality was 25.4% (159/626) in the qualitative group and 23.1% (142/614) in the quantitative group over the duration of the trials. There were no statistically significant differences between the use of quantitative cultures versus qualitative (risk ratio (RR) 0.91; 95% confidence interval (CI) 0.75 to 1.11). When we analysed all five studies, a total of 1367 patients were included. The cumulative all-cause mortality was 26.6% (184/692) in the non-invasive group and 24.7% (167/675) in the invasive group over the duration of the trials. The invasive versus non-invasive intervention analysis showed no evidence of mortality reduction (RR 0.93; 95% CI 0.78 to 1.11). The pooled data from trials did not show a significant influence on antibiotic change, but there was significant heterogeneity amongst the studies and the publication bias analysis for the antibiotic change analysis suggests that significant publication bias is likely (Egger's regression (intercept: 1.909; standard error: 0.436; P value (two-sided): 0.048). The analysis did not show significant differences in days on mechanical ventilation and in the length of ICU stay between either the quantitative versus qualitative culture groups or the invasive versus non-invasive method groups.</P>
<P>
<B>Quality of the evidence</B>
<BR/>The body of evidence supports moderately robust conclusions regarding the objective of our review. We use the word moderately because the sample size was of moderate size, even though this was the largest sample size evaluated to date: five RCTs with a total of 1367 participants. The results were consistent with respect to the mortality outcome, days on ventilation and days in the ICU. However, the results were less consistent with respect to antibiotic change.</P>
<P>
<B>Conclusion</B>
<BR/>Evidence from trials included in this review indicates that there is no clinical advantage in the use of quantitative over qualitative cultures, nor in using invasive over non-invasive diagnostic approaches. The evidence is current to October 2014.<BR/>
</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2014-10-21 11:32:46 +1000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2008-07-28 20:28:28 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Ventilator-associated pneumonia (VAP) is a common infectious disease in intensive care units (ICUs). The best diagnostic approach to resolve this condition remains uncertain.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2014-10-16 05:47:40 +1000" MODIFIED_BY="[Empty name]">
<P>To evaluate whether quantitative cultures of respiratory secretions and invasive strategies are effective in reducing mortality in immunocompetent patients with VAP, compared with qualitative cultures and non-invasive strategies. We also considered changes in antibiotic use, length of ICU stay and mechanical ventilation.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2014-10-21 11:28:08 +1000" MODIFIED_BY="[Empty name]">
<P>We searched CENTRAL (2014, Issue 9), MEDLINE (1966 to October week 2, 2014), EMBASE (1974 to October 2014) and LILACS (1982 to October 2014).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2011-12-02 07:35:34 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Randomised controlled trials (RCTs) comparing respiratory samples processed quantitatively or qualitatively, obtained by invasive or non-invasive methods from immunocompetent patients with VAP and which analysed the impact of these methods on antibiotic use and mortality rates.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors independently reviewed the trials identified in the search results and assessed studies for suitability, methodology and quality. We analysed data using Review Manager software. We pooled the included studies to yield the risk ratio (RR) for mortality and antibiotic change with 95% confidence intervals (CI).</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2014-10-21 11:32:46 +1000" MODIFIED_BY="[Empty name]">
<P>Of the 5064 references identified from the electronic databases (605 from the updated search in October 2014), five RCTs (1367 patients) met the inclusion criteria. Three studies compared invasive methods using quantitative cultures versus non-invasive methods using qualitative cultures, and we used them to answer the main objective of this review. The other two studies compared invasive versus non-invasive methods, both using quantitative cultures. We combined all five studies to compare invasive versus non-invasive interventions for diagnosing VAP. The studies that compared quantitative and qualitative cultures (1240 patients) showed no statistically significant differences in mortality rates (RR 0.91; 95% CI 0.75 to 1.11). The analysis of all five RCTs showed there was no evidence of reduction in mortality in the invasive group versus the non-invasive group (RR 0.93; 95% CI 0.78 to 1.11). There were no significant differences between the interventions with respect to the number of days on mechanical ventilation, length of ICU stay or antibiotic change.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<P>There is no evidence that the use of quantitative cultures of respiratory secretions results in reduced mortality, reduced time in ICU and on mechanical ventilation, or higher rates of antibiotic change when compared to qualitative cultures in patients with VAP. We observed similar results when invasive strategies were compared with non-invasive strategies.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2014-10-23 06:46:13 +1000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<P>Ventilator-associated pneumonia (VAP) is a common infectious disease in intensive care units (ICUs), occurring in 10% to 20% of patients on mechanical ventilation for more than 48 hours. VAP accounts for approximately 90% of all nosocomial pneumonia in ICU patients (<LINK REF="REF-ATS_x002f_IDSA-2005" TYPE="REFERENCE">ATS/IDSA 2005</LINK>). The mortality rate of patients with VAP is twice as high as that of patients without VAP (<LINK REF="REF-Safdar-2005" TYPE="REFERENCE">Safdar 2005</LINK>), and the crude mortality rate ranges from 24% to 57% (<LINK REF="REF-Chastre-2002" TYPE="REFERENCE">Chastre 2002</LINK>). Many of these patients succumb to an underlying disease rather than to VAP itself. However, it is believed that VAP-attributable mortality ranges from 15% to 47% (<LINK REF="REF-Chastre-2002" TYPE="REFERENCE">Chastre 2002</LINK>). VAP significantly increases costs and the length of hospital stay by an average of six days (<LINK REF="REF-Safdar-2005" TYPE="REFERENCE">Safdar 2005</LINK>).</P>
<P>VAP represents a great challenge to clinical practice and has triggered numerous discussions regarding the best diagnostic approach (<LINK REF="REF-Grossman-2000" TYPE="REFERENCE">Grossman 2000</LINK>; <LINK REF="REF-Shorr-2005" TYPE="REFERENCE">Shorr 2005</LINK>). Isolated non-invasive techniques are sensitive but not specific. Invasive methods used to obtain lower respiratory secretions are theoretically more specific for diagnosis and can potentially lead to a more appropriate use of antibiotics (<LINK REF="REF-Chastre-2002" TYPE="REFERENCE">Chastre 2002</LINK>). For this reason, various invasive methods are used with the aim of identifying the causative organism and trying to prevent the antibiotic treatment of colonising or contaminant organisms that are not causing the disease. However, there is no evidence or consensus regarding the superiority of one specific invasive technique over another (<LINK REF="REF-Grossman-2000" TYPE="REFERENCE">Grossman 2000</LINK>). In a recent meta-analysis, which evaluated the existing randomised and observational clinical studies that have examined the use of invasive strategies and outcomes for VAP, the authors found no changes in mortality (<LINK REF="REF-Shorr-2005" TYPE="REFERENCE">Shorr 2005</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2011-11-21 21:05:51 +1000" MODIFIED_BY="Liz Dooley">
<P>Quantitative cultures determining a threshold limit in the bacteria growth are recommended to differentiate infectious organisms (associated with a higher concentration of pathogenic bacteria) from colonising organisms (associated with lower bacterial concentrations), present due to the contamination with bacteria from the oropharynx that occurs in the collection of all respiratory samples (<LINK REF="REF-Chastre-2002" TYPE="REFERENCE">Chastre 2002</LINK>). Nevertheless, there is no clear evidence or expert consensus to determine if quantitative cultures (that report the number of bacterial colonies) are associated with better clinical outcomes than qualitative ones (that report the presence or absence of pathogenic bacteria) (<LINK REF="REF-Grossman-2000" TYPE="REFERENCE">Grossman 2000</LINK>). There are no systematic reviews or adequately powered large, controlled, prospective studies that compare the impact of quantitative versus qualitative cultures, independent of the method used to collect respiratory secretions (invasive or non-invasive), on clinical outcomes.</P>
</INTERVENTION>
<THEORY MODIFIED="2011-11-21 21:06:22 +1000" MODIFIED_BY="[Empty name]">
<P>The use of invasive and non-invasive techniques with or without quantitative cultures of specimens helps to differentiate between colonisation and infection. When culture results are available from these techniques, they allow the precise identification of the offending organisms and their susceptibility patterns. Such data are thought to be valuable for optimal antibiotic selection, improving identification of patients with true VAP and helping decisions on whether or not to treat.</P>
</THEORY>
<IMPORTANCE MODIFIED="2008-07-28 21:11:04 +1000" MODIFIED_BY="Jenny Bellorini">
<P>The assessment of clinical outcomes is the most appropriate way to evaluate the best management of patients with VAP. Studies using other diagnostic criteria as the gold standard to confirm the efficacy of a diagnostic method, such as autopsies for histological confirmation and identification of the causative pathogen, would introduce bias because the non-surviving patients differ from those who survive. </P>
<P>It is also important to evaluate whether there is any difference in mortality and secondary outcomes such as antibiotic change, ICU stay and duration of mechanical ventilation, when quantitative cultures are used following both invasive and non-invasive methods of obtaining samples. This Cochrane review examines the evidence to determine how the use of quantitative or qualitative cultures, as well as invasive or non-invasive techniques, may influence clinical outcomes in patients with VAP (<LINK REF="REF-Porzecanski-2006" TYPE="REFERENCE">Porzecanski 2006</LINK>; <LINK REF="REF-Shorr-2005" TYPE="REFERENCE">Shorr 2005</LINK>; <LINK REF="REF-Torres-2004" TYPE="REFERENCE">Torres 2004</LINK>).</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2014-10-16 08:02:13 +1000" MODIFIED_BY="Liz Dooley">
<SUBSECTION>
<HEADING LEVEL="2">Primary objectives</HEADING>
<P>To evaluate whether quantitative cultures of respiratory secretions are effective in reducing mortality in immunocompetent patients with VAP, compared with qualitative cultures. We also considered changes in antibiotic use, length of ICU stay and mechanical ventilation.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Secondary objective</HEADING>
<P>To evaluate whether invasive or non-invasive strategies are effective in influencing the same outcomes, independent of the culture type used.</P>
</SUBSECTION>
</OBJECTIVES>
<METHODS MODIFIED="2014-10-21 11:31:21 +1000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2011-12-02 07:33:22 +1000" MODIFIED_BY="Jenny Bellorini">
<CRIT_STUDIES MODIFIED="2011-09-20 16:02:07 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Randomised controlled trials (RCTs) comparing respiratory samples processed quantitatively or qualitatively and obtained by invasive or non-invasive methods from patients with VAP, where the impact on antibiotic use and mortality rates have been analysed. We excluded studies investigating severe community-acquired pneumonia.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2008-07-28 21:13:16 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Immunocompetent patients, 18 years or older, on mechanical ventilation for more than 48 hours with suspected VAP (new or progressive radiological infiltration, fever, tracheobronchial purulent secretion, leucopenia or leucocytosis).</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2011-12-02 07:33:22 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Invasive and non-invasive methods using quantitative or qualitative cultures of respiratory secretions from patients with suspected VAP. Invasive methods are those that obtain samples from the lower respiratory tract with the benefit of bypassing the upper airways, which are usually colonised by many micro-organisms. These invasive methods include bronchoalveolar lavage (BAL), protected specimen brush (PSB) obtained by fibreoptic bronchoscopy, and non-bronchoscopic techniques (blinded) such as mini BAL, blinded bronchial sampling (BBS) and blinded sampling protected brushes (BPSB). The non-invasive method used to obtain respiratory samples from patients on mechanical ventilation is endotracheal aspirate (ETA) (<LINK REF="REF-Ioanas-2001" TYPE="REFERENCE">Ioanas 2001</LINK>). Quantitative cultures of respiratory samples are those that determine a threshold count to differentiate between infection and colonisation of the lower airways.<BR/>
</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2011-11-21 21:07:18 +1000" MODIFIED_BY="Jenny Bellorini">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2011-11-21 21:07:18 +1000" MODIFIED_BY="Liz Dooley">
<OL>
<LI>Twenty-eight day mortality.</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2011-09-20 16:03:16 +1000" MODIFIED_BY="Jenny Bellorini">
<OL>
<LI>Change of antibiotics (any change in the patients' antibiotic prescription based on the results of the diagnostic strategy used).</LI>
<LI>Number of days on mechanical ventilation.</LI>
<LI>Length of ICU stay.</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2014-10-21 11:31:21 +1000" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2014-10-21 11:31:21 +1000" MODIFIED_BY="[Empty name]">
<P>For this update we searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2014, Issue 9) (accessed 21 October 2014), MEDLINE (June 2011 to October week 2, 2014), EMBASE (June 2011 to October 2014) and LILACS (June 2011 to October 2014). Please see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for details of earlier searches.</P>
<P>We used the search strategy described in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK> to search MEDLINE and CENTRAL. We combined the MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity- and precision-maximising version (2008 revision); Ovid format (<LINK REF="REF-Lefebvre-2011" TYPE="REFERENCE">Lefebvre 2011</LINK>). We adapted the search strategy to search EMBASE (see <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>) and LILACS (see <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>). There were no language or publication restrictions.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2014-02-17 12:55:15 +1000" MODIFIED_BY="Jenny Bellorini">
<P>We searched WHO ICTRP and ClinicalTrials.gov for completed and ongoing trials (17 February 2014). We reviewed bibliographies of all included studies for additional references.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2014-10-03 19:11:04 +1000" MODIFIED_BY="[Empty name]">
<P>The overall risk of bias is presented graphically in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and summarised in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>.</P>
<STUDY_SELECTION MODIFIED="2011-10-05 12:42:07 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors (DCB, PJZT) independently reviewed and selected potential trials from the search results. We assessed the studies for suitability, methodology and quality. There were no disagreements between these review authors on study selection.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2011-09-20 16:05:54 +1000" MODIFIED_BY="Jenny Bellorini">
<P>We extracted data using a standardised form. Information extracted included:</P>
<UL>
<LI>age and gender of participants;</LI>
<LI>number of participants;</LI>
<LI>criteria for suspected diagnosis of VAP (usually defined as a combination of findings: new or progressive radiographic infiltrate; new fever; leukocytosis or leucopenia; purulent sputum; decline in oxygenation);</LI>
<LI>type of intervention (invasive versus non-invasive; quantitative versus qualitative cultures);</LI>
<LI>randomisation method;</LI>
<LI>disease severity score (i.e. APACHE II);</LI>
<LI>previous use of antibiotic;</LI>
<LI>appropriateness of initial antibiotic choice (Yes or No);</LI>
<LI>duration of mechanical ventilation before the diagnosis of VAP;</LI>
<LI>mortality at 28 days;</LI>
<LI>antibiotic change (Yes or No);</LI>
<LI>ICU stay (days);</LI>
<LI>number of days of mechanical ventilation; and</LI>
<LI>most common isolated pathogens.</LI>
</UL>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2014-10-03 19:09:45 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors (DCB, PJZT) independently assessed the methodological quality of included studies. A third review author (AK) resolved any potential disagreements. We used the Cochrane Collaboration's 'Risk of bias' tool for assessing trial quality (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). In this tool, the risk of bias is evaluated according seven domains: sequence generation; allocation concealment; blinding of participants and personnel; blinding of outcome assessment; incomplete outcome data; selective reporting; and other sources of bias.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2014-07-16 14:09:26 +1000" MODIFIED_BY="Liz Dooley">
<P>We presented all point estimates as risk ratios (RR). We used forest plots to display results. We combined trials using Review Manager software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>) and analyses were by intention-to-treat (ITT). We calculated a fixed-effect risk ratio (RR) with 95% confidence intervals (CI) for individual studies for dichotomous variables. We calculated the mean difference (MD) with 95% CI for continuous variables. When the trial authors reported standard deviations (SD), we used them directly. In the <LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK> study, the SDs were not available for these variables, so we analysed them by transforming 95% CI into SD with the formula: SE = (Upper-Lower limit of 95% CI)/(1.96*2), SD = SE* sqrt (N).</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<P>We only included studies with a randomised, parallel design, therefore participants should be individually randomised to one of two intervention groups (invasive versus non-invasive; or quantitative versus qualitative culture). We collected and analysed a single measurement for each outcome from each participant.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2014-10-03 19:10:21 +1000" MODIFIED_BY="[Empty name]">
<P>If we considered missing data to be 'not at random', we would conduct sensitivity analyses to assess how sensitive results were considering the inclusion or not of studies with missing data.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2011-11-21 21:09:43 +1000" MODIFIED_BY="[Empty name]">
<P>We quantified inconsistency among the pooled estimates by using the I<SUP>2</SUP> statistic [(Q - df)/Q] x 100% test, where Q is the Chi<SUP>2</SUP> test and df its degrees of freedom. This illustrates the percentage of the variability in effect estimates resulting from heterogeneity rather than sampling error (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). If heterogeneity was found, we used a random-effects model.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2011-09-20 16:16:09 +1000" MODIFIED_BY="[Empty name]">
<P>We evaluated publication bias analysis by using the Egger's regression method. This method is equivalent to a weighted regression of treatment effect on its standard error, with weights inversely proportional to the variance of the effect size (<LINK REF="REF-Sterne-2001" TYPE="REFERENCE">Sterne 2001</LINK>). We used the Comprehensive Meta-Analysis version 2.0 (Biostat, Englewood, New Jersey) software.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2014-10-03 19:11:04 +1000" MODIFIED_BY="[Empty name]">
<P>We planned to perform a meta-analysis if studies performed the same interventions (invasive or non-invasive; quantitative or qualitative cultures) and reported the same clinical outcomes (mainly survival and antibiotic change). In addition, if studies were suspected to be at risk of bias, or serious publication or reporting biases (or both) were likely, we would not undertake a meta-analysis and we would describe a systematic synthesis of the studies' findings.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2011-09-20 16:36:52 +1000" MODIFIED_BY="[Empty name]">
<P>We did not plan to perform a subgroups analysis.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<P>We had planned an additional sensitivity analysis if the eligibility/quality of some studies in the meta-analysis were dubious: first, including all studies and second, only including those that are definitely known to be eligible. Fortunately, we considered all identified studies to be of the same good quality. We performed sensitivity analyses comparing random-effects and fixed-effect models.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2014-10-23 06:46:13 +1000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2014-10-23 06:46:13 +1000" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2014-10-23 06:46:13 +1000" MODIFIED_BY="[Empty name]">
<P>We updated our searches in October 2014 and retrieved a total of 605 new records after duplicates were removed from this current search as well as when compared with the search results of the last update (<LINK REF="REF-Berton-2012" TYPE="REFERENCE">Berton 2012</LINK>). No new trials were included or excluded in this 2014 update. The updated electronic database searches identified a total of 4903 articles (3931 from the first publication of this review (<LINK REF="REF-Berton-2008" TYPE="REFERENCE">Berton 2008</LINK>); 528 from the second publication (<LINK REF="REF-Berton-2012" TYPE="REFERENCE">Berton 2012</LINK>); and 605 from this current search update, i.e. October 2014). The review of titles yielded 76 articles that we examined further. Of these, a review of the abstracts, and whenever required, the full text, yielded six articles that appeared to fulfil the inclusion criteria. Five of these met the inclusion criteria and were included in the analysis. We excluded the sixth trial because it had a cross-over design and was not randomised (<LINK REF="STD-Cai-2001" TYPE="STUDY">Cai 2001</LINK>).</P>
<P>We identified no additional RCTs following handsearching of the reference lists of identified included studies. All included studies were published in peer-reviewed literature and their characteristics are described in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<P>Three of the five included studies compared invasive methods using quantitative cultures versus the non-invasive method using qualitative cultures (<LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK>; <LINK REF="STD-Fagon-2000" TYPE="STUDY">Fagon 2000</LINK>; <LINK REF="STD-Sol_x00e9_-Viol_x00e1_n-2000" TYPE="STUDY">Solé Violán 2000</LINK>). The other two included studies compared invasive versus non-invasive methods both using quantitative cultures (<LINK REF="STD-Ruiz--2000" TYPE="STUDY">Ruiz 2000</LINK>; <LINK REF="STD-Sanchez_x002d_Nieto-1998" TYPE="STUDY">Sanchez-Nieto 1998</LINK>). We combined them with the three previous studies to compare invasive versus non-invasive interventions.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<P>We excluded one study because it was not randomised and had a cross-over design (<LINK REF="STD-Cai-2001" TYPE="STUDY">Cai 2001</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2014-10-03 19:12:48 +1000" MODIFIED_BY="[Empty name]">
<P>Overall, the risk of bias of the included studies was low. </P>
<ALLOCATION MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<P>All included studies described the use of computer-generated randomisation tables of variable and undisclosed block size, providing, in this way, an adequate generation sequence. One study reported the utilisation of a central telephone system (<LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK>), and the other studies, a computer-generated random number table (<LINK REF="STD-Fagon-2000" TYPE="STUDY">Fagon 2000</LINK>; <LINK REF="STD-Ruiz--2000" TYPE="STUDY">Ruiz 2000</LINK>; <LINK REF="STD-Sanchez_x002d_Nieto-1998" TYPE="STUDY">Sanchez-Nieto 1998</LINK>), indicating an adequate concealment allocation.</P>
</ALLOCATION>
<BLINDING MODIFIED="2011-11-21 21:30:17 +1000" MODIFIED_BY="[Empty name]">
<P>Two studies stated that investigators were aware of the study intervention (<LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK>; <LINK REF="STD-Fagon-2000" TYPE="STUDY">Fagon 2000</LINK>). The other three did not address this issue, but are probably not blinded. However, the review authors judged that the main outcomes (mortality and antibiotic change) are not likely to be influenced by lack of blinding.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2011-09-20 16:20:51 +1000" MODIFIED_BY="[Empty name]">
<P>All studies had low incomplete outcome data with almost 100% adequate follow-up.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2014-10-03 19:12:48 +1000" MODIFIED_BY="[Empty name]">
<P>The methodological section of the <LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK> and <LINK REF="STD-Fagon-2000" TYPE="STUDY">Fagon 2000</LINK> studies pre-specified (primary and secondary) outcomes that were of interest in the review and they reported them in the pre-specified way. The other included studies did not give sufficient information to permit judgement.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2011-07-26 07:30:23 +1000" MODIFIED_BY="[Empty name]">
<P>The included studies appear to be free of other sources of bias.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2014-10-03 19:23:38 +1000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Primary outcome</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. 28-day mortality</HEADING>
<P>The three RCTs that compared quantitative cultures versus qualitative cultures consisted of a total of 1240 patients, including 614 in the invasive quantitative arm and 626 in the non-invasive qualitative arm (<LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK>; <LINK REF="STD-Fagon-2000" TYPE="STUDY">Fagon 2000</LINK>; <LINK REF="STD-Sol_x00e9_-Viol_x00e1_n-2000" TYPE="STUDY">Solé Violán 2000</LINK>).</P>
<P>The cumulative all-cause mortality was 25.4% (159/626) in the qualitative group and 23.1% (142/614) in the quantitative group over the duration of the trials. There were no statistically significant differences between the use of quantitative cultures versus qualitative (risk ratio (RR) 0.91; 95% confidence interval (CI) 0.75 to 1.11; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). The intervention effect was statistically homogeneous across the studies with respect to mortality (P value = 0.43; I<SUP>2</SUP> statistic = 0%).</P>
<P>When we analysed all five studies, a total of 1367 patients were included. The cumulative all-cause mortality was 26.6% (184/692) in the non-invasive group and 24.7% (167/675) in the invasive group over the duration of the trials. The invasive versus non-invasive intervention analysis showed no evidence of mortality reduction (RR 0.93; 95% CI 0.78 to 1.11; <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). The test for heterogeneity among the studies was not significant (P value = 0.32; I<SUP>2</SUP> statistic = 14%).</P>
<P>The <LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK> trial excluded patients infected or colonised with <I>Pseudomonas</I> species and methicillin-resistant <I>Staphylococcus aureus</I> (<I>S. aureus</I>), which are also causes of VAP and associated with a poorer prognosis. Thus, we performed a sensitivity analysis excluding this trial: no difference was found regarding mortality (quantitative versus qualitative: RR 0.82; 95% CI 0.64 to 1.06; invasive versus non-invasive: RR 0.88; 95% CI 0.71 to 1.09).</P>
<P>Only two studies compared invasive versus non-invasive interventions, both using quantitative culture and including a total of 127 patients (<LINK REF="STD-Ruiz--2000" TYPE="STUDY">Ruiz 2000</LINK>; <LINK REF="STD-Sanchez_x002d_Nieto-1998" TYPE="STUDY">Sanchez-Nieto 1998</LINK>). The combined effect of these trials did not show changes in mortality (RR 1.14; 95% CI 0.54 to 2.41; <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>).</P>
<P>The publication bias analysis for the mortality analysis shows the following: Egger's regression (intercept: 0.917; standard error: 1.829; P value (two-sided): 0.704), which suggests that significant publication bias is unlikely.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Change of antibiotics</HEADING>
<P>This endpoint could not be evaluated in the Fagon study because they reported antibiotic-free days instead of the percentage or absolute value of antibiotic change (<LINK REF="STD-Fagon-2000" TYPE="STUDY">Fagon 2000</LINK>). Antibiotic-free days means the number of days without antibiotics at day 28 after randomisation, and the number of days for which the patient is alive and not receiving antibiotics. The rate of antibiotic change was evaluated by the inclusion of two trials (<LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK>; <LINK REF="STD-Sol_x00e9_-Viol_x00e1_n-2000" TYPE="STUDY">Solé Violán 2000</LINK>). The pooled data from these two trials did not show a significant influence on antibiotic change (RR 1.53; 95% CI 0.54 to 4.39; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>; <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>). There was significant heterogeneity among the studies (P value = 0.02, I<SUP>2</SUP> statistic = 81%).</P>
<P>We found similar results with the summary data from the four studies that reported antibiotic change (<LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK>; <LINK REF="STD-Ruiz--2000" TYPE="STUDY">Ruiz 2000</LINK>; <LINK REF="STD-Sanchez_x002d_Nieto-1998" TYPE="STUDY">Sanchez-Nieto 1998</LINK>; <LINK REF="STD-Sol_x00e9_-Viol_x00e1_n-2000" TYPE="STUDY">Solé Violán 2000</LINK>), and compared invasive versus non-invasive interventions (RR 1.67; 95% CI 0.87 to 3.21; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>). The test for detection of heterogeneity was significant (P value = 0.01, I<SUP>2</SUP> statistic = 73%).</P>
<P>The publication bias analysis for the antibiotic change analysis showed the following: Egger's regression (intercept: 1.909; standard error: 0.436; P value (two-sided): 0.048), which suggests that significant publication bias is likely.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Number of days on mechanical ventilation</HEADING>
<P>The analysis did not show significant differences in days on mechanical ventilation between either the quantitative versus qualitative culture groups (mean difference (MD) 0.58; 95% CI -0.51 to 1.68; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>; <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>), or the invasive versus non-invasive method groups (MD 0.61; 95% CI -0.47 to 1.68; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>). For this analysis we did not include the data from <LINK REF="STD-Fagon-2000" TYPE="STUDY">Fagon 2000</LINK>, because this information was given as mechanical ventilation-free days (as explained for antibiotic change). However, no difference was found between these interventions in the <LINK REF="STD-Fagon-2000" TYPE="STUDY">Fagon 2000</LINK> study (invasive quantitative: 7.8 ± 9.8; non-invasive qualitative: 7 ± 9.4; P value &gt; 0.2).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Length of intensive care unit (ICU) stay</HEADING>
<P>The length of ICU stay was the same for the quantitative versus qualitative comparison (MD 0.95; 95% CI -0.14 to 2.04; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>; <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>) and invasive versus non-invasive analysis (MD 0.94; 95% CI -0.13 to 2.01; <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2014-10-03 19:19:14 +1000" MODIFIED_BY="[Empty name]">
<P>Although the current management strategy for patients with suspected ventilator-associated pneumonia (VAP) recommends obtaining a lower respiratory tract sample for quantitative or semi-quantitative cultures (<LINK REF="REF-ATS_x002f_IDSA-2005" TYPE="REFERENCE">ATS/IDSA 2005</LINK>), this systematic review of the best available evidence did not show that quantitative cultures were associated with a significant reduction in mortality in patients with VAP (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). Similarly, we found no significant reduction in mortality when invasive methods were compared to non-invasive methods (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>).</P>
<P>Interestingly, if we consider the lowest mortality rate among the included studies (18% - <LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK>), the pooled sample of included trials gave us statistical power of more than 90% with a significance level of 0.1% to detect an absolute mortality reduction of 9% (a similar mortality reduction observed at day 14 in the study by <LINK REF="STD-Fagon-2000" TYPE="STUDY">Fagon 2000</LINK>; the only study that demonstrated improvement in mortality). However, to confirm the risk ratio reduction of 9% (or absolute risk reduction of 1.6%) suggested by this meta-analysis estimate, it would be necessary to conduct a trial with more than 7500 patients in each arm in order to achieve a statistical power of 80% and a significance level of 5%. It remains to be seen whether the risks and costs of invasive methods are worth taking in the context of a potential 1.6% reduction in mortality.</P>
<P>The main advantage of using quantitative cultures is that fewer patients may be treated with unnecessary antibiotics, because it is possible to differentiate colonising pathogens from infecting ones (<LINK REF="REF-ATS_x002f_IDSA-2005" TYPE="REFERENCE">ATS/IDSA 2005</LINK>). Another possible advantage is that quantitative methods allow antibiotics to be used with more precision, therefore improving appropriate antibiotic use and potentially decreasing mortality. However, the results of <LINK REF="REF-Luna-1997" TYPE="REFERENCE">Luna 1997</LINK> suggest that subsequent changes of inadequate antimicrobial therapy following culture results did not reduce the greater risk of hospital mortality, although the use of adequate empirical treatment from the beginning did. One of the major challenges associated with VAP, therefore, is how to choose the most adequate antibiotic from the beginning of treatment, since multiple-drug resistant bacteria, polymicrobial cultures and late-onset VAP are all recognised risk factors for inadequate initial treatment (<LINK REF="REF-Teixeira-2007" TYPE="REFERENCE">Teixeira 2007</LINK>). The impact of these strategies on bacterial resistance would be an important analysis, but unfortunately most studies did not provide enough information to apply the meta-analytic methodology.</P>
<P>The pooled data from trials that compared invasive quantitative versus non-invasive qualitative strategies did not show significant changes in antibiotic prescribing (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). Similar results were observed when invasive versus non-invasive methods were analysed (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>). Unlike our mortality outcome analysis, the antibiotic change analyses showed statistically significant publication bias (P value = 0.048). An important issue in the three studies, where only a small number of patients were included is that antibiotics were continued in patients with negative cultures (<LINK REF="STD-Ruiz--2000" TYPE="STUDY">Ruiz 2000</LINK>; <LINK REF="STD-Sanchez_x002d_Nieto-1998" TYPE="STUDY">Sanchez-Nieto 1998</LINK>; <LINK REF="STD-Sol_x00e9_-Viol_x00e1_n-2000" TYPE="STUDY">Solé Violán 2000</LINK>). The other two studies allowed therapy to be discontinued when the culture results were negative, but antimicrobial therapy could be continued based on clinical judgement (<LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK>; <LINK REF="STD-Fagon-2000" TYPE="STUDY">Fagon 2000</LINK>). In the study conducted by <LINK REF="STD-Fagon-2000" TYPE="STUDY">Fagon 2000</LINK>, the outcomes of those patients who had their antibiotics stopped were not reported, and in the Canadian trial (<LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK>), a significant discontinuation or modification of antibiotics occurred in the invasive quantitative arm only for those patients with low or moderate pre-test likelihood of pneumonia.</P>
<P>The studies by <LINK REF="STD-Fagon-2000" TYPE="STUDY">Fagon 2000</LINK>, <LINK REF="STD-Sanchez_x002d_Nieto-1998" TYPE="STUDY">Sanchez-Nieto 1998</LINK> and <LINK REF="STD-Sol_x00e9_-Viol_x00e1_n-2000" TYPE="STUDY">Solé Violán 2000</LINK> showed a higher rate of antibiotic change in the invasive method group without mortality reduction. However, the Canadian trial, which included the largest number of patients, showed a high rate of antibiotic change without a difference between the study arms. This could be partially explained by the fact that the research team from this trial monitored the patients and reminded the clinical personnel to adjust antimicrobial therapy as soon as possible, according to culture results. This could result in a more rational antibiotic use and should be considered for future studies.</P>
<P>The lower mortality rate (around 20%) in the studies by <LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK> and <LINK REF="STD-Sol_x00e9_-Viol_x00e1_n-2000" TYPE="STUDY">Solé Violán 2000</LINK> probably reflects the higher rates of initial appropriate antibiotic therapy (<LINK REF="REF-Alvarez_x002d_Lerma-1996" TYPE="REFERENCE">Alvarez-Lerma 1996</LINK>; <LINK REF="REF-Iregui-2002" TYPE="REFERENCE">Iregui 2002</LINK>; <LINK REF="REF-Luna-1997" TYPE="REFERENCE">Luna 1997</LINK>). The study by <LINK REF="STD-Fagon-2000" TYPE="STUDY">Fagon 2000</LINK> had similar rates of initial appropriate antibiotic selection compared to the <LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK> and <LINK REF="STD-Sol_x00e9_-Viol_x00e1_n-2000" TYPE="STUDY">Solé Violán 2000</LINK> trials, but had a greater mortality rate (<I>see </I>'<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' table). This may reflect the significantly higher rate of appropriate initial antibiotic in the non-invasive/qualitative arms in the two later studies (<LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK>; <LINK REF="STD-Sol_x00e9_-Viol_x00e1_n-2000" TYPE="STUDY">Solé Violán 2000</LINK>). The empirical antimicrobial therapy based on the results of direct microscopic examination of respiratory secretions (<LINK REF="STD-Fagon-2000" TYPE="STUDY">Fagon 2000</LINK>), or the empirical broad spectrum antibiotic therapy (<LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK>), guided the initial appropriate treatment choices in a high percentage of cases (above 90%). However, using a strategy similar to <LINK REF="STD-Fagon-2000" TYPE="STUDY">Fagon 2000</LINK>, <LINK REF="STD-Ruiz--2000" TYPE="STUDY">Ruiz 2000</LINK> found only a 73% rate of appropriate initial antibiotic prescribing. It is possible that differences in mortality could reflect the variability of multiple-drug resistant pathogens, which were lower in the <LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK> and <LINK REF="STD-Sol_x00e9_-Viol_x00e1_n-2000" TYPE="STUDY">Solé Violán 2000</LINK> studies.</P>
<P>Initial antimicrobial therapy based on local patterns of micro-organism prevalence and antibiotic susceptibility was used to elaborate empirical strategies with a higher appropriateness rate to treat patients with VAP. This could be further improved by avoiding antibiotics that patients have recently received (<LINK REF="REF-ATS_x002f_IDSA-2005" TYPE="REFERENCE">ATS/IDSA 2005</LINK>). Information about micro-organisms and their antibiotic sensitivities suggests that empirical antibiotic therapy would be appropriate (<LINK REF="REF-Ibrahim-2002" TYPE="REFERENCE">Ibrahim 2002</LINK>). Based on these findings, it seems reasonable to assume that the knowledge of local micro-organism patterns would be more important than the methods used to obtain and cultivate respiratory secretions in reducing the morbidity and mortality of patients with VAP. In fact, results from the <LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK> trial strongly suggest that in the setting of appropriate initial antibiotic, the method of respiratory culture collection may not affect survival outcomes. Larger randomised prospective trials are required to better answer these questions.</P>
<P>Days on mechanical ventilation and length of intensive care unit (ICU) stay were the same between the intervention groups in the included trials (<I>see</I> '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' table) and in the pooled data. The duration of these outcomes was shorter in the <LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK> study and this finding should not be attributed to initial antibiotic choice (<LINK REF="REF-Dupont-2001" TYPE="REFERENCE">Dupont 2001</LINK>), as other studies had the same rate of appropriate antibiotic selection (<LINK REF="STD-Fagon-2000" TYPE="STUDY">Fagon 2000</LINK>; <LINK REF="STD-Sol_x00e9_-Viol_x00e1_n-2000" TYPE="STUDY">Solé Violán 2000</LINK>). A possible explanation for patients spending fewer days on mechanical ventilation and in ICU could be related to 'standardisation' of key aspects of the protocol, such as adjustment of antibiotic therapy and discontinuation of mechanical ventilation. This protocol standardisation deserves further evaluation in future trials.</P>
<SUMMARY_OF_RESULTS MODIFIED="2011-11-21 21:14:30 +1000" MODIFIED_BY="[Empty name]">
<P>The studies that compared quantitative and qualitative cultures showed no statistically significant differences in mortality rates. The analysis of all five randomised controlled trials (RCTs) showed there was no evidence of mortality reduction in the invasive group versus the non-invasive group. There were no significant differences between the interventions with respect to the number of days on mechanical ventilation, length of ICU stay or antibiotic change.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<P>All identified and evaluated studies that were included in our systematic review and meta-analysis provided sufficient evidence to address the objectives of this review. The relevant participants, interventions and outcomes were all fully investigated by our analysis. The results of our review provide support to optimise the current practice for patients with VAP, i.e. quantitative and qualitative cultures of respiratory secretions are associated with similar morbidity or mortality outcomes in patients with VAP.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2014-10-03 19:19:14 +1000" MODIFIED_BY="[Empty name]">
<P>The body of evidence supports moderately robust conclusions regarding the objective of our review. We use the word moderately because the sample size was of moderate size, even though this was the largest sample size evaluated to date: five randomised clinical trials with a total of 1240 participants. The results were consistent with respect to the mortality outcome, days on ventilation and days in the ICU. However, the results were less consistent with respect to antibiotic change. The overall results of this review led to a robust internal validity.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2011-09-20 11:54:51 +1000" MODIFIED_BY="[Empty name]">
<P>The likelihood that all relevant studies were identified is very high based on our unlimited, exhaustive and replicated literature search. However, due to the number of included randomised trials, publication bias cannot be totally excluded.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2011-11-21 21:15:08 +1000" MODIFIED_BY="[Empty name]">
<P>No other published systematic review has addressed our objectives with a similar methodological approach. The only other systematic review that has addressed the use of invasive diagnostic methods in patients with VAP was performed by Shorr et al (<LINK REF="REF-Shorr-2005" TYPE="REFERENCE">Shorr 2005</LINK>). They analysed a similar set of randomised trials plus five observational studies but they did not include the most recent and largest randomised trial on VAP (<LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK>). Similar to our conclusions, they did not find mortality differences between invasive and non-invasive diagnostic methods. However, different from our conclusion, they found that the invasive approach led to more changes in the antibiotic regimen; this was likely due to several reasons: 1) our antibiotic change analysis (which showed no significant differences between invasive and non-invasive techniques) was based on randomised studies only, while Shorr et al used additional data from non-randomised observational studies; 2) our analysis used risk ratios (which are the most appropriate outcome measure to be used in meta-analysis of randomised studies), while Shorr et al used odds ratio. It is well known that odds ratio leads to an over-estimation of outcome measures when the rate of the outcome being measured is high (&gt; 10% to 15%); because the rate of outcomes in the antibiotic change analysis was very high (up to 42%), the use of odds ratio in Shorr et al likely produced spuriously inflated estimates; and 3) our review included the largest VAP study (<LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK>) to date, which provided a substantial amount of data on antibiotic change, while Shorr et al did not include this study in their meta-analysis (it was not published at that time).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>There is no evidence that the use of quantitative cultures of respiratory secretions results in lower mortality compared to qualitative cultures in patients with ventilator-associated pneumonia (VAP). We observed similar results when invasive and non-invasive strategies were compared.</LI>
<LI>There is no evidence that the use of quantitative cultures of respiratory secretions results in a higher rate of antibiotic change, or a reduction in intensive care unit (ICU) stay and length of time on mechanical ventilation, compared to qualitative cultures in patients with VAP.</LI>
</OL>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>It is unlikely that a multicentre randomised controlled trial with a sample size of fewer than 15,000 patients would settle the question of quantitative versus qualitative cultures because of the potential absolute mortality reduction of 1% to 2% at the most (based on our meta-analysis and on the most recent, largest clinical trial (<LINK REF="STD-CCCTG-2006" TYPE="STUDY">CCCTG 2006</LINK>)). It is unlikely that the risks and costs of invasive methods are worth taking in the context of a 1% to 2% absolute reduction in mortality.</LI>
<LI>We suggest that future VAP studies consider evaluating the best strategy based on specific and local bacteriological patterns to guide empirical selection of appropriate antibiotic therapy.</LI>
</OL>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2011-09-20 16:44:50 +1000" MODIFIED_BY="Liz Dooley">
<P>The review authors would like to thank the following people for commenting on the draft protocol and/or review: Elizabeth Lissiman, Antoni Torres, Bernard Allaouchiche, Terry Neeman, Allen Cheng, Carlos Luna and Janet Wale. We further would like to acknowledge Elizabeth Dooley for all her support and Hayley Edmonds for her assistance with the organisation of translations.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2014-07-18 07:01:36 +1000" MODIFIED_BY="[Empty name]">
<P>Danilo Cortozi Berton: none known.<BR/>Andre Kalil: none known.<BR/>Paulo José Zimermann Teixeira: none known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2011-10-07 02:24:13 +1000" MODIFIED_BY="[Empty name]">
<P>Danilo Cortozi Berton (DCB), Andre Kalil (AK) and Paulo José Zimermann Teixeira (PJZT) wrote the draft protocol.<BR/>AK revised the methodology section.<BR/>PJZT and DCB were responsible for identifying studies and extracting data.<BR/>All review authors contributed to the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2008-07-28 22:08:55 +1000" MODIFIED_BY="Jenny Bellorini"/>
<PUBLIC_NOTES MODIFIED="2008-07-28 22:08:55 +1000" MODIFIED_BY="Jenny Bellorini"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2008-07-28 22:12:03 +1000" MODIFIED_BY="Jenny Bellorini">
<INCLUDED_STUDIES MODIFIED="2008-07-28 22:10:56 +1000" MODIFIED_BY="Jenny Bellorini">
<STUDY DATA_SOURCE="PUB" ID="STD-CCCTG-2006" MODIFIED="2008-07-04 08:08:50 +1000" MODIFIED_BY="[Empty name]" NAME="CCCTG 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-07-04 08:08:50 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>The Canadian Clinical Care Trials Group</AU>
<TI>A randomised trial of diagnostic techniques for ventilator-associated pneumonia</TI>
<SO>New England Journal of Medicine</SO>
<YR>2006</YR>
<VL>355</VL>
<NO>25</NO>
<PG>2619-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fagon-2000" MODIFIED="2008-07-28 22:10:44 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Fagon 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-07-28 22:10:44 +1000" MODIFIED_BY="Jenny Bellorini" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stéphan F et al</AU>
<TI>Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomised trial</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2000</YR>
<VL>132</VL>
<PG>621-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ruiz--2000" MODIFIED="2008-03-11 13:57:11 +1000" MODIFIED_BY="[Empty name]" NAME="Ruiz  2000" YEAR="2000">
<REFERENCE MODIFIED="2008-03-11 13:57:11 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ruiz M, Torres A, Ewig S, Marcos MA, Alcon A, Lledo R et al</AU>
<TI>Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2000</YR>
<VL>162</VL>
<PG>119-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sanchez_x002d_Nieto-1998" NAME="Sanchez-Nieto 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sanchez-Nieto JM, Torres A, Garcia-Cordoba F, El-Ebiary M, Carrillo A, Ruiz J et al</AU>
<TI>Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>1998</YR>
<VL>157</VL>
<PG>371-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sol_x00e9_-Viol_x00e1_n-2000" MODIFIED="2008-07-28 22:10:56 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Solé Violán 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-07-28 22:10:56 +1000" MODIFIED_BY="Jenny Bellorini" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Solé Violán J, Fernandez JA, Benitez AB, Cardenosa Cendrero JA, Rodriguez de Castro F</AU>
<TI>Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia</TI>
<SO>Critical Care Medicine</SO>
<YR>2000</YR>
<VL>28</VL>
<PG>2737-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2008-07-28 22:12:03 +1000" MODIFIED_BY="Jenny Bellorini">
<STUDY DATA_SOURCE="PUB" ID="STD-Cai-2001" MODIFIED="2008-07-28 22:12:03 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Cai 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-07-28 22:12:03 +1000" MODIFIED_BY="Jenny Bellorini" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cai S, Zhang J, Qian G</AU>
<TI>Impact of quantitative and qualitative pathogen culture on the outcome of ventilator-associated pneumonia</TI>
<SO>Chinese Journal of Tuberculosis and Respiratory Diseases</SO>
<YR>2001</YR>
<VL>24</VL>
<PG>494-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Alvarez_x002d_Lerma-1996" MODIFIED="2008-03-05 15:01:29 +1000" MODIFIED_BY="[Empty name]" NAME="Alvarez-Lerma 1996" TYPE="JOURNAL_ARTICLE">
<AU>Alvarez-Lerma F</AU>
<TI>Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group</TI>
<SO>Intensive Care Medicine</SO>
<YR>1996</YR>
<VL>22</VL>
<PG>387-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ATS_x002f_IDSA-2005" NAME="ATS/IDSA 2005" TYPE="JOURNAL_ARTICLE">
<AU>American Thoracic Society; Infectious Diseases Society of America</AU>
<TI>Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2005</YR>
<VL>171</VL>
<PG>388-416</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chastre-2002" NAME="Chastre 2002" TYPE="JOURNAL_ARTICLE">
<AU>Chastre J, Fagon JY</AU>
<TI>Ventilator-associated pneumonia</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2002</YR>
<VL>165</VL>
<PG>867-903</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dupont-2001" MODIFIED="2008-03-05 15:03:30 +1000" MODIFIED_BY="[Empty name]" NAME="Dupont 2001" TYPE="JOURNAL_ARTICLE">
<AU>Dupont H, Mentec H, Sollet JP, Bleichner G</AU>
<TI>Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia</TI>
<SO>Intensive Care Medicine</SO>
<YR>2001</YR>
<VL>27</VL>
<PG>355-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grossman-2000" MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]" NAME="Grossman 2000" TYPE="JOURNAL_ARTICLE">
<AU>Grossman RF, Fein A</AU>
<TI>Evidence-based assessment of diagnostic tests for ventilator-associated pneumonia: executive summary</TI>
<SO>Chest</SO>
<YR>2000</YR>
<VL>117</VL>
<NO>4 Suppl 2</NO>
<PG>177-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Altman DG, Sterne JAC</AU>
<TI>Chapter 8: Assessing risk of bias in included studies</TI>
<SO>In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ibrahim-2002" NAME="Ibrahim 2002" TYPE="JOURNAL_ARTICLE">
<AU>Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, Kollef MH</AU>
<TI>Experience with a clinical guideline for the treatment of ventilator-associated pneumonia</TI>
<SO>Critical Care Medicine</SO>
<YR>2002</YR>
<VL>29</VL>
<PG>1109-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ioanas-2001" NAME="Ioanas 2001" TYPE="JOURNAL_ARTICLE">
<AU>Ioanas M, Ferrer, R, Angrill J, Ferrer M, Torres A</AU>
<TI>Microbial investigation in ventilator-associated pneumonia</TI>
<SO>European Respiratory Journal</SO>
<YR>2001</YR>
<VL>17</VL>
<NO>4</NO>
<PG>791-801</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Iregui-2002" MODIFIED="2008-03-05 15:20:02 +1000" MODIFIED_BY="[Empty name]" NAME="Iregui 2002" TYPE="JOURNAL_ARTICLE">
<AU>Iregui M, Ward S, Sherman G, Fraser VJ, Kollef M</AU>
<TI>Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia</TI>
<SO>Chest</SO>
<YR>2002</YR>
<VL>122</VL>
<PG>262-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lefebvre-2011" MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]" NAME="Lefebvre 2011" TYPE="OTHER">
<AU>Lefebvre C, Manheimer E, Glanville J</AU>
<TI>Chapter 6: Searching for studies</TI>
<SO>In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Luna-1997" MODIFIED="2008-07-28 22:12:45 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Luna 1997" TYPE="JOURNAL_ARTICLE">
<AU>Luna CM, Vujacich P, Niederman MS, Vay C, Gherardy C, Matera J et al</AU>
<TI>Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia</TI>
<SO>Chest</SO>
<YR>1997</YR>
<VL>111</VL>
<PG>676-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Porzecanski-2006" NAME="Porzecanski 2006" TYPE="JOURNAL_ARTICLE">
<AU>Porzecanski I, Bowton DL</AU>
<TI>Diagnosis and treatment of ventilator-associated pneumonia</TI>
<SO>Chest</SO>
<YR>2006</YR>
<VL>130</VL>
<PG>597-604</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2014-07-16 14:09:32 +1000" MODIFIED_BY="Liz Dooley" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Safdar-2005" NAME="Safdar 2005" TYPE="JOURNAL_ARTICLE">
<AU>Safdar N, Dezfulian C, Collard HR, Saint S</AU>
<TI>Clinical and economic consequences of ventilator-associated pneumonia: a systematic review</TI>
<SO>Critical Care Medicine</SO>
<YR>2005</YR>
<VL>33</VL>
<PG>2184-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shorr-2005" NAME="Shorr 2005" TYPE="JOURNAL_ARTICLE">
<AU>Shorr AF, Sherner JH, Jackson WL, Kollef MH</AU>
<TI>Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis</TI>
<SO>Critical Care Medicine</SO>
<YR>2005</YR>
<VL>33</VL>
<PG>46-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sterne-2001" MODIFIED="2011-11-21 21:19:11 +1000" MODIFIED_BY="[Empty name]" NAME="Sterne 2001" TYPE="JOURNAL_ARTICLE">
<AU>Sterne JA, Egger M, Smith GD</AU>
<TI>Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis</TI>
<SO>BMJ</SO>
<YR>2001</YR>
<VL>323</VL>
<PG>101-5</PG>
<IDENTIFIERS MODIFIED="2008-07-04 01:08:49 +1000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Teixeira-2007" MODIFIED="2011-09-20 11:57:30 +1000" MODIFIED_BY="[Empty name]" NAME="Teixeira 2007" TYPE="JOURNAL_ARTICLE">
<AU>Teixeira PJZ, Seligman R, Hertz FT, Cruz DB, Fachel JMG</AU>
<TI>Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes</TI>
<SO>Journal of Hospital Infection</SO>
<YR>2007</YR>
<VL>65</VL>
<PG>361-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Torres-2004" NAME="Torres 2004" TYPE="JOURNAL_ARTICLE">
<AU>Torres A, Ewig S</AU>
<TI>Diagnosing ventilator-associated pneumonia</TI>
<SO>New England Journal of Medicine</SO>
<YR>2004</YR>
<VL>350</VL>
<PG>433-5</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2014-07-16 14:09:11 +1000" MODIFIED_BY="Liz Dooley">
<REFERENCE ID="REF-Berton-2008" MODIFIED="2014-07-16 14:09:11 +1000" MODIFIED_BY="Liz Dooley" NAME="Berton 2008" TYPE="COCHRANE_REVIEW">
<AU>Berton DC, Kalil AC, Cavalcanti M, Teixeira PJZ</AU>
<TI>Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2014-07-16 14:09:11 +1000" MODIFIED_BY="Liz Dooley">
<IDENTIFIER MODIFIED="2014-07-16 14:09:11 +1000" MODIFIED_BY="Liz Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD006482.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Berton-2012" MODIFIED="2014-07-16 14:09:00 +1000" MODIFIED_BY="Liz Dooley" NAME="Berton 2012" TYPE="COCHRANE_REVIEW">
<AU>Berton DC, Kalil AC, Teixeira PJZ</AU>
<TI>Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2014-07-16 14:09:00 +1000" MODIFIED_BY="Liz Dooley">
<IDENTIFIER MODIFIED="2014-07-16 14:09:00 +1000" MODIFIED_BY="Liz Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD006482.pub3"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2014-10-16 08:07:36 +1000" MODIFIED_BY="Liz Dooley">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2014-10-16 08:07:36 +1000" MODIFIED_BY="Liz Dooley" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-CCCTG-2006">
<CHAR_METHODS MODIFIED="2011-09-20 15:40:11 +1000" MODIFIED_BY="[Empty name]">
<P>Duration: 28 days<BR/>Parallel design<BR/>Blinded assessment of outcomes: not met<BR/>Withdrawals described and were they acceptable: met</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-11-21 21:15:49 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Sample size = 739<BR/>APACHE II (severity)<BR/>- Invasive quantitative = 20.1 ± 6.4<BR/>- Non-invasive qualitative = 19.8 ± 6.2<BR/>
<BR/>Duration on mechanical ventilation before study (days): not informed<BR/>
<BR/>Previous use of antibiotics<BR/>- Invasive quantitative = 227/365 (62.2%)<BR/>- Non-invasive qualitative = 241/374 (64.4%)<BR/>
<BR/>VAP suspected: new or persistent radiographic infiltrate plus any 2 of the following: fever &gt; 38.3 ºC; leukocytosis or neutropenia, purulent endotracheal secretions, increasing oxygen requirement, potentially pathogenic bacteria from endotracheal secretion</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-03-05 15:40:20 +1000" MODIFIED_BY="[Empty name]">
<P>Invasive quantitative versus non-invasive qualitative</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-09-20 15:41:27 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Mortality<BR/>- Invasive quantitative = 69/365 (18.9%)<BR/>- Non-invasive qualitative = 69/374 (18.4%)<BR/>
<BR/>Antibiotic change<BR/>- Invasive quantitative = 271/365 (74.2%)<BR/>- Non-invasive qualitative = 279/474 (74.6%)<BR/>
<BR/>Intensive care unit (ICU) stay (days)<BR/>- Invasive quantitative = 12.3 (95% CI 10.9 to 13.8)<BR/>- Non-invasive qualitative = 12.2 (95% CI 10.9 to 14.2)<BR/>
<BR/>- Duration of mechanical ventilation (days)<BR/>- Invasive quantitative: 8.9 (95% CI 7.4 to 10.7)<BR/>- Non-invasive: qualitative: 8.8 (95% CI 7.0 to 10.7)<BR/>
<BR/>Appropriateness of initial antibiotic choice<BR/>- Invasive quantitative = 341/365 (93.4%)<BR/>- Non-invasive qualitative = 353/374 (94.3%)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<P>&#8213;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fagon-2000">
<CHAR_METHODS MODIFIED="2011-09-20 15:42:13 +1000" MODIFIED_BY="[Empty name]">
<P>Duration: 28 days<BR/>Parallel design<BR/>Blinded assessment of outcomes: not met<BR/>Withdrawals described and were they acceptable: met</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-11-21 21:15:58 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Sample size = 413<BR/>SAPS (severity)<BR/>- Invasive quantitative = 44 ± 15<BR/>- Non-invasive qualitative = 42 ± 14<BR/>
<BR/>Duration on mechanical ventilation before study (days)<BR/>- Invasive quantitative = 10.4 ± 10.2<BR/>- Non-invasive qualitative = 10.7 ± 10.0<BR/>
<BR/>Previous use of antibiotic<BR/>- Invasive quantitative = 105/204 (51.5%)<BR/>- Non-invasive qualitative = 103/109 (49.3%)<BR/>
<BR/>VAP suspected: new or progressive radiographic infiltrate plus 1 of the following: fever &gt; 38.3 ºC, leukocytosis or purulent tracheal secretion</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-03-05 15:40:49 +1000" MODIFIED_BY="[Empty name]">
<P>Invasive quantitative versus non-invasive qualitative</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-03-12 11:51:41 +1000" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>- Invasive quantitative = 63/204 (30.9%)<BR/>- Non-invasive qualitative = 81/209 (38.8%)<BR/>
<BR/>Antibiotic change not informed<BR/>
<BR/>Intensive care unit (ICU) stay (days)<BR/>- Invasive quantitative = 26.7 ± 23.9<BR/>- Non-invasive qualitative = 25.1 ± 28.5<BR/>
<BR/>Duration of mechanical ventilation (days) not informed<BR/>
<BR/>Appropriateness of initial antibiotic choice<BR/>- Invasive quantitative = 203/204 (99%)<BR/>- Non-invasive qualitative = 185/209 (88.5%)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<P>&#8213;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ruiz--2000">
<CHAR_METHODS MODIFIED="2011-09-20 15:42:18 +1000" MODIFIED_BY="[Empty name]">
<P>Duration: 30 days<BR/>Parallel design<BR/>Blinded assessment of outcomes: not met<BR/>Withdrawals described and were they acceptable: met</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-11-21 21:16:13 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Sample size = 76<BR/>APACHE II (severity)<BR/>- Invasive quantitative = 20 ± 6<BR/>- Non-invasive quantitative = 19 ± 6<BR/>
<BR/>Duration on mechanical ventilation before study (days)<BR/>- Invasive quantitative = 6 ± 4<BR/>- Non-invasive quantitative = 6.2 ± 5</P>
<P>
<BR/>Previous use of antibiotic<BR/>- Invasive quantitative = 26/33 (70%)<BR/>- Non-invasive quantitative = 33/39 (87%)<BR/>
<BR/>VAP suspected: new or progressive radiographic infiltrate plus 2 of the following: fever &gt; 38.3 ºC or hypothermia &lt; 35 ºC, leukocytosis or leucopenia, purulent tracheal secretion</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-03-05 15:41:07 +1000" MODIFIED_BY="[Empty name]">
<P>Invasive quantitative versus non-invasive quantitative</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-07-28 22:10:00 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Mortality<BR/>- Invasive quantitative = 14/37 (38%)<BR/>- Non-invasive quantitative = 18/39 (46%)<BR/>
<BR/>Antibiotic change<BR/>- Invasive quantitative: 10/37 (28%)<BR/>- Non-invasive quantitative: 7/39 (18%)<BR/>
<BR/>Intensive care unit (ICU) stay (days)<BR/>- Invasive quantitative = 21 ± 15<BR/>- Non-invasive quantitative = 21 ± 18<BR/>
<BR/>Duration of mechanical ventilation (days)<BR/>- Invasive quantitative = 19 ± 15<BR/>- Non-invasive quantitative = 20 ± 24<BR/>
<BR/>Appropriateness of initial antibiotic choice<BR/>- Invasive quantitative = 27/37 (73%)<BR/>- Non-invasive quantitative = 31/39 (79.4%)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<P>&#8213;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sanchez_x002d_Nieto-1998">
<CHAR_METHODS MODIFIED="2011-09-20 15:42:22 +1000" MODIFIED_BY="[Empty name]">
<P>Duration: not informed<BR/>Parallel design<BR/>Blinded assessment of outcomes: not met<BR/>Withdrawals described and were they acceptable: met</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-11-21 21:16:23 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Sample size = 51<BR/>APACHE II (severity)<BR/>- Invasive quantitative = 15 ± 5<BR/>- Non-invasive quantitative = 18 ± 5<BR/>
<BR/>Duration on mechanical ventilation before study (days)<BR/>- Invasive quantitative = 11 ± 8<BR/>- Non-invasive quantitative = 11 ± 15<BR/>
<BR/>Previous use of antibiotic<BR/>- Invasive quantitative = 20/24 (83%)<BR/>- Non-invasive qualitative = 19/27 (70%)<BR/>
<BR/>VAP suspected: new or progressive radiographic infiltrate plus 2 of the following: fever &gt; 38.3 ºC or hypothermia, &lt; 35 ºC; leukocytosis or leucopenia, purulent respiratory secretions</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-03-05 15:41:24 +1000" MODIFIED_BY="[Empty name]">
<P>Invasive quantitative versus non-invasive quantitative</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-09-20 15:44:51 +1000" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>- Invasive quantitative = 11/24 (46%)<BR/>- Non-invasive qualitative = 7/27 (26%)<BR/>
<BR/>Antibiotic change<BR/>- Invasive quantitative = 10/24 (42%)<BR/>- Non-invasive qualitative = 4/27 (15%)<BR/>
</P>
<P>
<BR/>Intensive care unit (ICU) stay (days)<BR/>- Invasive quantitative = 28 ± 17<BR/>- Non-invasive qualitative = 26 ± 18<BR/>
<BR/>Duration of mechanical ventilation (days)<BR/>- Invasive quantitative: 23 ± 12<BR/>- Non-invasive quantitative: 20 ± 17<BR/>
<BR/>Appropriateness of initial antibiotic choice<BR/>- Invasive quantitative = 14/24 (58.3%)<BR/>- Non-invasive qualitative = 23/27 (85.1%)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<P>&#8213;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sol_x00e9_-Viol_x00e1_n-2000">
<CHAR_METHODS MODIFIED="2011-09-20 15:42:27 +1000" MODIFIED_BY="[Empty name]">
<P>Duration: not informed<BR/>Parallel design<BR/>Blinded assessment of outcomes: not met<BR/>Withdrawals described and were they acceptable: met</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-10-10 10:52:24 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Sample size = 88<BR/>APACHE II (severity)<BR/>- Invasive quantitative = 15.8 ± 0.9<BR/>- Non-invasive qualitative = 15.0 ± 0.9<BR/>
<BR/>Duration on mechanical ventilation before study (days)<BR/>- Invasive quantitative = 7.8 ± 1.1<BR/>- Non-invasive qualitative = 7.3 ± 0.9<BR/>
<BR/>Previous use of antibiotic<BR/>- Invasive quantitative = 16/45 (35.5%)<BR/>- Non-invasive qualitative = 19/43 (44.1%)<BR/>
<BR/>VAP suspected: new radiographic infiltrate plus 2 of the following: fever &gt; 38.5 ºC, leukocytosis or leukopenia, purulent tracheal secretions</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-03-06 13:52:34 +1000" MODIFIED_BY="[Empty name]">
<P>Invasive quantitative versus non-invasive qualitative<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-07-28 22:10:33 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Mortality<BR/>- Invasive quantitative = 10/45 (22.2%)<BR/>- Non-invasive qualitative = 9/43 (20.9%)<BR/>
<BR/>Antibiotic change<BR/>- Invasive quantitative = 15/45 (33.3%)<BR/>- Non-invasive qualitative = 5/43 (11.6%)<BR/>
<BR/>Intensive care unit (ICU) stay (days)<BR/>- Invasive quantitative = 23.6 ± 3.1<BR/>- Non-invasive qualitative = 22.4 ± 3.1<BR/>
<BR/>Duration of mechanical ventilation (days)<BR/>- Invasive quantitative: 19.9 ± 2.8<BR/>- Non-invasive qualitative: 19.2 ± 3.0<BR/>
<BR/>Appropriateness of initial antibiotic choice<BR/>- Invasive quantitative = 42/43 (93.3%) PS: 2/45 inadequacy (isolated organism treated with only 1 effective antibiotic)<BR/>- Non-invasive qualitative = 42/43 (97.6%) PS: 1/43 inadequacy</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<P>&#8213;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>APACHE: acute physiology and chronic health evaluation<BR/>CI: confidence interval<BR/>ICU: intensive care unit<BR/>PS: positive specimen<BR/>SAPS: simplified acute physiologic score<BR/>VAP: ventilator-associated pneumonia</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2011-11-21 21:16:48 +1000" MODIFIED_BY="Liz Dooley" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2011-11-21 21:16:48 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Cai-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-11-21 21:16:48 +1000" MODIFIED_BY="Liz Dooley">
<P>The study is not clearly randomised and is a cross-over study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2011-11-21 21:16:05 +1000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 07:43:01 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-CCCTG-2006">
<DESCRIPTION>
<P>Central telephone system, with a variable, undisclosed block size</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-21 21:16:05 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fagon-2000">
<DESCRIPTION>
<P>Computer-generated random number tables were used to assign patients in blocks of 8, with stratification according to treatment centre</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 10:51:48 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ruiz--2000">
<DESCRIPTION>
<P>Computer-generated randomisation table into 1 of the 2 groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 10:52:07 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sanchez_x002d_Nieto-1998">
<DESCRIPTION>
<P>Computer-generated randomisation table into 1 of the 2 groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 10:52:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sol_x00e9_-Viol_x00e1_n-2000">
<DESCRIPTION>
<P>Computer-generated randomisation table into 1 of the 2 groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2011-10-10 10:52:43 +1000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 10:50:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-CCCTG-2006">
<DESCRIPTION>
<P>As above</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 10:51:31 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fagon-2000">
<DESCRIPTION>
<P>As above</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 10:51:52 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ruiz--2000">
<DESCRIPTION>
<P>As above</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 10:52:12 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sanchez_x002d_Nieto-1998">
<DESCRIPTION>
<P>As above</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 10:52:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sol_x00e9_-Viol_x00e1_n-2000">
<DESCRIPTION>
<P>As above</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-10-10 07:54:59 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-CCCTG-2006">
<DESCRIPTION>
<P>Physicians were aware of the patient's treatment assignments</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-10-10 08:08:14 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fagon-2000">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-10-10 08:37:01 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ruiz--2000">
<DESCRIPTION>
<P>Open study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-10-10 08:36:13 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sanchez_x002d_Nieto-1998">
<DESCRIPTION>
<P>Open study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sol_x00e9_-Viol_x00e1_n-2000">
<DESCRIPTION>
<P>It is not stated in the paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2011-10-10 10:52:48 +1000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-10-10 10:51:13 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-CCCTG-2006">
<DESCRIPTION>
<P>1 patient withdrew consent 2 days after randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-10-10 08:09:52 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fagon-2000">
<DESCRIPTION>
<P>All patients were followed up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-10-10 08:33:05 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ruiz--2000">
<DESCRIPTION>
<P>All patients were followed up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-10-10 08:39:49 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sanchez_x002d_Nieto-1998">
<DESCRIPTION>
<P>All patients were followed up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-10-10 10:52:48 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sol_x00e9_-Viol_x00e1_n-2000">
<DESCRIPTION>
<P>3 patients were excluded because of transfer to another institution</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2011-10-10 08:45:33 +1000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 07:58:17 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-CCCTG-2006">
<DESCRIPTION>
<P>Primary and secondary outcomes have been reported in the pre-specified way and adequately reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 08:05:42 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fagon-2000">
<DESCRIPTION>
<P>Primary and secondary outcomes have been reported in the pre-specified way and adequately reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 08:33:42 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ruiz--2000">
<DESCRIPTION>
<P>No data to evaluate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 08:40:33 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sanchez_x002d_Nieto-1998">
<DESCRIPTION>
<P>No data to evaluate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 08:45:33 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sol_x00e9_-Viol_x00e1_n-2000">
<DESCRIPTION>
<P>No data to evaluate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2011-10-10 08:58:16 +1000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 07:58:44 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-CCCTG-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 08:58:16 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fagon-2000">
<DESCRIPTION>
<P>Not detected</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 08:58:09 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ruiz--2000">
<DESCRIPTION>
<P>Not detected</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 08:58:01 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sanchez_x002d_Nieto-1998">
<DESCRIPTION>
<P>Not detected</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-10 08:57:52 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sol_x00e9_-Viol_x00e1_n-2000">
<DESCRIPTION>
<P>Not detected</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2011-10-05 12:54:33 +1000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2011-10-05 12:54:33 +1000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2014-10-03 19:01:01 +1000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2014-10-03 19:00:29 +1000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Quantitative versus qualitative culture</NAME>
<DICH_OUTCOME CHI2="1.6952285396860436" CI_END="1.1063213964139225" CI_START="0.7501554630033442" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9109956308113625" ESTIMABLE="YES" EVENTS_1="142" EVENTS_2="159" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.04388131178999721" LOG_CI_START="-0.12484872363777884" LOG_EFFECT_SIZE="-0.04048370592389084" METHOD="MH" MODIFIED="2014-10-03 19:00:03 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4284361370715333" P_Q="1.0" P_Z="0.3469532217405653" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="614" TOTAL_2="626" WEIGHT="99.99999999999999" Z="0.9405154852290747">
<NAME>Mortality</NAME>
<GROUP_LABEL_1>Quantitative culture</GROUP_LABEL_1>
<GROUP_LABEL_2>Qualitative culture</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours quantitative</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours qualitative</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3844113843239876" CI_START="0.7583895035657717" EFFECT_SIZE="1.0246575342465754" ESTIMABLE="YES" EVENTS_1="69" EVENTS_2="69" LOG_CI_END="0.14126516193728766" LOG_CI_START="-0.12010768644927675" LOG_EFFECT_SIZE="0.010578737744005463" ORDER="3" O_E="0.0" SE="0.15353170495873386" STUDY_ID="STD-CCCTG-2006" TOTAL_1="365" TOTAL_2="374" VAR="0.023571984427535702" WEIGHT="43.30799337984226"/>
<DICH_DATA CI_END="1.0405137039811827" CI_START="0.6102327253184137" EFFECT_SIZE="0.7968409586056645" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="81" LOG_CI_END="0.017247804417146313" LOG_CI_START="-0.21450450589697195" LOG_EFFECT_SIZE="-0.09862835073991279" ORDER="2" O_E="0.0" SE="0.1361324542709508" STUDY_ID="STD-Fagon-2000" TOTAL_1="204" TOTAL_2="209" VAR="0.018532045105832513" WEIGHT="50.84352814333174"/>
<DICH_DATA CI_END="2.357413722222806" CI_START="0.4781796144876314" EFFECT_SIZE="1.0617283950617284" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" LOG_CI_END="0.37243580717894825" LOG_CI_START="-0.3204089424491123" LOG_EFFECT_SIZE="0.026013432364917995" ORDER="1" O_E="0.0" SE="0.4069804355683459" STUDY_ID="STD-Sol_x00e9_-Viol_x00e1_n-2000" TOTAL_1="45" TOTAL_2="43" VAR="0.16563307493540053" WEIGHT="5.848478476825983"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.352105793839261" CI_END="4.390898490905384" CI_START="0.5350055014737247" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5326952890405372" ESTIMABLE="YES" EVENTS_1="286" EVENTS_2="284" I2="81.31576544785256" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.6425533971706076" LOG_CI_START="-0.2716417520957874" LOG_EFFECT_SIZE="0.18545582253741008" METHOD="MH" MODIFIED="2014-10-03 19:00:11 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.020697325992739657" P_Q="1.0" P_Z="0.4264936905870442" Q="0.0" RANDOM="YES" SCALE="230.47" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.48536723636865287" TOTALS="YES" TOTAL_1="410" TOTAL_2="417" WEIGHT="100.0" Z="0.7952059977309199">
<NAME>Antibiotic change</NAME>
<GROUP_LABEL_1>Quantitative culture</GROUP_LABEL_1>
<GROUP_LABEL_2>Qualitative culture</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours quantitative</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours qualitative</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.083082505649292" CI_START="0.914589286365333" EFFECT_SIZE="0.9952766730495409" ESTIMABLE="YES" EVENTS_1="271" EVENTS_2="279" LOG_CI_END="0.034661541005197194" LOG_CI_START="-0.03877389031556992" LOG_EFFECT_SIZE="-0.0020561746551863644" ORDER="1083" O_E="0.0" SE="0.0431363358690663" STUDY_ID="STD-CCCTG-2006" TOTAL_1="365" TOTAL_2="374" VAR="0.0018607434722088963" WEIGHT="59.18624789675924"/>
<DICH_DATA CI_END="7.206148392982281" CI_START="1.1403842010498524" EFFECT_SIZE="2.8666666666666667" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="5" LOG_CI_END="0.8577032011101408" LOG_CI_START="0.05705119193766979" LOG_EFFECT_SIZE="0.4573771965239053" ORDER="1084" O_E="0.0" SE="0.47030695347927404" STUDY_ID="STD-Sol_x00e9_-Viol_x00e1_n-2000" TOTAL_1="45" TOTAL_2="43" VAR="0.22118863049095605" WEIGHT="40.81375210324076"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.18014966211258437" CI_END="1.675964146302535" CI_START="-0.5062702052982146" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.5848469705021602" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2014-10-03 19:00:21 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.67124466056521" P_Q="1.0" P_Z="0.29346286730491766" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="410" TOTAL_2="417" UNITS="" WEIGHT="100.0" Z="1.050555361124029">
<NAME>Duration on mechanical ventilation (days)</NAME>
<GROUP_LABEL_1>Quantitative culture</GROUP_LABEL_1>
<GROUP_LABEL_2>Qualitative culture</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours quantitative</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours qualitative</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.5906306795371044" CI_START="-2.390630679537105" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="8.8" MODIFIED="2008-08-08 10:54:07 +1000" MODIFIED_BY="[Empty name]" ORDER="17" SD_1="16.16" SD_2="18.34" SE="1.2707532889292261" STUDY_ID="STD-CCCTG-2006" TOTAL_1="365" TOTAL_2="374" WEIGHT="19.19217158297319"/>
<CONT_DATA CI_END="1.9137931278075895" CI_START="-0.5137931278075909" EFFECT_SIZE="0.6999999999999993" ESTIMABLE="YES" MEAN_1="19.9" MEAN_2="19.2" MODIFIED="2008-08-08 10:54:56 +1000" MODIFIED_BY="[Empty name]" ORDER="18" SD_1="2.8" SD_2="3.0" SE="0.6192935877300988" STUDY_ID="STD-Sol_x00e9_-Viol_x00e1_n-2000" TOTAL_1="45" TOTAL_2="43" WEIGHT="80.80782841702681"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.7818320028764969" CI_END="2.0373329117614363" CI_START="-0.14228433633433513" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="0.9475242877135506" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2014-10-03 19:00:29 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.6764371701807287" P_Q="1.0" P_Z="0.0883674454606519" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="614" TOTAL_2="626" UNITS="" WEIGHT="100.00000000000001" Z="1.7040730247643245">
<NAME>ICU stay (days)</NAME>
<GROUP_LABEL_1>Quantitative culture</GROUP_LABEL_1>
<GROUP_LABEL_2>Qualitative culture</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours quantitative</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours qualitative</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.295759820510746" CI_START="-2.095759820510743" EFFECT_SIZE="0.10000000000000142" ESTIMABLE="YES" MEAN_1="12.3" MEAN_2="12.2" MODIFIED="2008-08-08 11:01:33 +1000" MODIFIED_BY="[Empty name]" ORDER="19" SD_1="14.1" SD_2="16.3" SE="1.1203062085990445" STUDY_ID="STD-CCCTG-2006" TOTAL_1="365" TOTAL_2="374" WEIGHT="24.63376607560265"/>
<CONT_DATA CI_END="6.6680942055256285" CI_START="-3.4680942055256327" EFFECT_SIZE="1.5999999999999979" ESTIMABLE="YES" MEAN_1="26.7" MEAN_2="25.1" MODIFIED="2008-08-08 11:04:30 +1000" MODIFIED_BY="[Empty name]" ORDER="20" SD_1="23.9" SD_2="28.5" SE="2.5858098646210395" STUDY_ID="STD-Fagon-2000" TOTAL_1="204" TOTAL_2="209" WEIGHT="4.623928636294334"/>
<CONT_DATA CI_END="2.4957184304070257" CI_START="-0.09571843040701977" EFFECT_SIZE="1.2000000000000028" ESTIMABLE="YES" MEAN_1="23.6" MEAN_2="22.4" MODIFIED="2008-08-08 11:03:07 +1000" MODIFIED_BY="[Empty name]" ORDER="21" SD_1="3.1" SD_2="3.1" SE="0.6610929795789536" STUDY_ID="STD-Sol_x00e9_-Viol_x00e1_n-2000" TOTAL_1="45" TOTAL_2="43" WEIGHT="70.74230528810303"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2014-10-03 19:01:01 +1000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Invasive versus non-invasive method</NAME>
<DICH_OUTCOME CHI2="4.676359067828721" CI_END="1.1146154711158194" CI_START="0.7814703028455952" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9332946425268203" ESTIMABLE="YES" EVENTS_1="167" EVENTS_2="184" I2="14.4633690017897" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.047125066868035574" LOG_CI_START="-0.10708752123448415" LOG_EFFECT_SIZE="-0.029981227183224254" METHOD="MH" MODIFIED="2014-10-03 19:01:01 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3221450618618473" P_Q="1.0" P_Z="0.44600482759365523" Q="0.0" RANDOM="NO" SCALE="3.7" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="675" TOTAL_2="692" WEIGHT="100.0" Z="0.7620924622880725">
<NAME>Mortality</NAME>
<GROUP_LABEL_1>Invasive</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-invasive</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours invasive</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-invasive</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3844113843239876" CI_START="0.7583895035657717" EFFECT_SIZE="1.0246575342465754" ESTIMABLE="YES" EVENTS_1="69" EVENTS_2="69" LOG_CI_END="0.14126516193728766" LOG_CI_START="-0.12010768644927675" LOG_EFFECT_SIZE="0.010578737744005463" ORDER="1085" O_E="0.0" SE="0.15353170495873386" STUDY_ID="STD-CCCTG-2006" TOTAL_1="365" TOTAL_2="374" VAR="0.023571984427535702" WEIGHT="37.5539244630713"/>
<DICH_DATA CI_END="1.0405137039811827" CI_START="0.6102327253184137" EFFECT_SIZE="0.7968409586056645" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="81" LOG_CI_END="0.017247804417146313" LOG_CI_START="-0.21450450589697195" LOG_EFFECT_SIZE="-0.09862835073991279" ORDER="1086" O_E="0.0" SE="0.1361324542709508" STUDY_ID="STD-Fagon-2000" TOTAL_1="204" TOTAL_2="209" VAR="0.018532045105832513" WEIGHT="44.088258686661746"/>
<DICH_DATA CI_END="1.3988277881586868" CI_START="0.48047696983065397" EFFECT_SIZE="0.8198198198198198" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="18" LOG_CI_END="0.14576425112084268" LOG_CI_START="-0.3183274240519704" LOG_EFFECT_SIZE="-0.08628158646556386" ORDER="1087" O_E="0.0" SE="0.2726097472873527" STUDY_ID="STD-Ruiz--2000" TOTAL_1="37" TOTAL_2="39" VAR="0.07431607431607432" WEIGHT="9.656471175766514"/>
<DICH_DATA CI_END="3.8250149783694636" CI_START="0.8170736311425607" EFFECT_SIZE="1.7678571428571428" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.5826331401459683" LOG_CI_START="-0.08773880496326922" LOG_EFFECT_SIZE="0.2474471675913495" ORDER="1089" O_E="0.0" SE="0.39377979895181275" STUDY_ID="STD-Sanchez_x002d_Nieto-1998" TOTAL_1="24" TOTAL_2="27" VAR="0.15506253006253007" WEIGHT="3.6299188592176543"/>
<DICH_DATA CI_END="2.357413722222806" CI_START="0.4781796144876314" EFFECT_SIZE="1.0617283950617284" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" LOG_CI_END="0.37243580717894825" LOG_CI_START="-0.3204089424491123" LOG_EFFECT_SIZE="0.026013432364917995" ORDER="1088" O_E="0.0" SE="0.4069804355683459" STUDY_ID="STD-Sol_x00e9_-Viol_x00e1_n-2000" TOTAL_1="45" TOTAL_2="43" VAR="0.16563307493540053" WEIGHT="5.071426815282782"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="10.932426141141464" CI_END="3.213517908617355" CI_START="0.8721113307486139" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.674080457943639" ESTIMABLE="YES" EVENTS_1="306" EVENTS_2="295" I2="72.55869867064324" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.5069807245333408" LOG_CI_START="-0.05942807098080547" LOG_EFFECT_SIZE="0.22377632677626766" METHOD="MH" MODIFIED="2014-10-03 19:01:01 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.012096981947796293" P_Q="1.0" P_Z="0.12145819321893568" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.29946280727564917" TOTALS="YES" TOTAL_1="471" TOTAL_2="483" WEIGHT="99.99999999999997" Z="1.5486819574403898">
<NAME>Antibiotic change</NAME>
<GROUP_LABEL_1>Invasive</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-invasive</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours invasive</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-invasive</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.083082505649292" CI_START="0.914589286365333" EFFECT_SIZE="0.9952766730495409" ESTIMABLE="YES" EVENTS_1="271" EVENTS_2="279" LOG_CI_END="0.034661541005197194" LOG_CI_START="-0.03877389031556992" LOG_EFFECT_SIZE="-0.0020561746551863644" ORDER="1090" O_E="0.0" SE="0.0431363358690663" STUDY_ID="STD-CCCTG-2006" TOTAL_1="365" TOTAL_2="374" VAR="0.0018607434722088963" WEIGHT="36.73686607120184"/>
<DICH_DATA CI_END="3.5398069248137256" CI_START="0.6405456871163018" EFFECT_SIZE="1.505791505791506" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="7" LOG_CI_END="0.5489795745187971" LOG_CI_START="-0.19344988862830223" LOG_EFFECT_SIZE="0.17776484294524741" ORDER="1091" O_E="0.0" SE="0.43610674173771974" STUDY_ID="STD-Ruiz--2000" TOTAL_1="37" TOTAL_2="39" VAR="0.1901890901890902" WEIGHT="22.60725014084153"/>
<DICH_DATA CI_END="7.806391215655437" CI_START="1.0132923179838162" EFFECT_SIZE="2.8125" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="4" LOG_CI_END="0.8924503120673152" LOG_CI_START="0.005734750171522564" LOG_EFFECT_SIZE="0.4490925311194189" ORDER="1092" O_E="0.0" SE="0.5208611103704098" STUDY_ID="STD-Sanchez_x002d_Nieto-1998" TOTAL_1="24" TOTAL_2="27" VAR="0.27129629629629626" WEIGHT="19.39466730998482"/>
<DICH_DATA CI_END="7.206148392982281" CI_START="1.1403842010498524" EFFECT_SIZE="2.8666666666666667" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="5" LOG_CI_END="0.8577032011101408" LOG_CI_START="0.05705119193766979" LOG_EFFECT_SIZE="0.4573771965239053" ORDER="1093" O_E="0.0" SE="0.47030695347927404" STUDY_ID="STD-Sol_x00e9_-Viol_x00e1_n-2000" TOTAL_1="45" TOTAL_2="43" VAR="0.22118863049095605" WEIGHT="21.26121647797179"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.6446134437144231" CI_END="1.6833812404848614" CI_START="-0.46805391872946767" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.6076636608776969" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2014-10-03 19:01:01 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8861474227211064" P_Q="1.0" P_Z="0.2682217962868588" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="471" TOTAL_2="483" UNITS="" WEIGHT="100.0" Z="1.1071668926977853">
<NAME>Duration on mechanical ventilation (days)</NAME>
<GROUP_LABEL_1>Invasive</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-invasive</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours invasive</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-invasive</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.620901858299974" CI_START="-2.420901858299975" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="8.8" MODIFIED="2008-08-08 11:14:25 +1000" MODIFIED_BY="[Empty name]" ORDER="22" SD_1="16.6" SD_2="18.34" SE="1.286198051691014" STUDY_ID="STD-CCCTG-2006" TOTAL_1="365" TOTAL_2="374" WEIGHT="18.20893959522347"/>
<CONT_DATA CI_END="7.949615319755578" CI_START="-9.949615319755578" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="19.0" MEAN_2="20.0" MODIFIED="2008-08-08 11:14:54 +1000" MODIFIED_BY="[Empty name]" ORDER="24" SD_1="15.0" SD_2="24.0" SE="4.566214170438335" STUDY_ID="STD-Ruiz--2000" TOTAL_1="37" TOTAL_2="39" WEIGHT="1.444733672566905"/>
<CONT_DATA CI_END="11.010405104041476" CI_START="-5.010405104041476" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="23.0" MEAN_2="20.0" MODIFIED="2008-08-08 11:16:13 +1000" MODIFIED_BY="[Empty name]" ORDER="25" SD_1="12.0" SD_2="17.0" SE="4.087016479499893" STUDY_ID="STD-Sanchez_x002d_Nieto-1998" TOTAL_1="24" TOTAL_2="27" WEIGHT="1.8033813427250338"/>
<CONT_DATA CI_END="1.9137931278075895" CI_START="-0.5137931278075909" EFFECT_SIZE="0.6999999999999993" ESTIMABLE="YES" MEAN_1="19.9" MEAN_2="19.2" MODIFIED="2008-08-08 11:10:07 +1000" MODIFIED_BY="[Empty name]" ORDER="23" SD_1="2.8" SD_2="3.0" SE="0.6192935877300988" STUDY_ID="STD-Sol_x00e9_-Viol_x00e1_n-2000" TOTAL_1="45" TOTAL_2="43" WEIGHT="78.54294538948459"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.8901567657473993" CI_END="2.0124874615623582" CI_START="-0.13063537898014133" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="0.9409260412911085" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2014-10-03 19:01:01 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.9259687513194893" P_Q="1.0" P_Z="0.08524676841212028" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="675" TOTAL_2="692" UNITS="" WEIGHT="100.00000000000003" Z="1.7210223494044732">
<NAME>ICU stay (days)</NAME>
<GROUP_LABEL_1>Invasive</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-invasive</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours invasive</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-invasive</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.295759820510746" CI_START="-2.095759820510743" EFFECT_SIZE="0.10000000000000142" ESTIMABLE="YES" MEAN_1="12.3" MEAN_2="12.2" MODIFIED="2008-08-08 11:20:43 +1000" MODIFIED_BY="[Empty name]" ORDER="26" SD_1="14.1" SD_2="16.3" SE="1.1203062085990445" STUDY_ID="STD-CCCTG-2006" TOTAL_1="365" TOTAL_2="374" WEIGHT="23.815761406664613"/>
<CONT_DATA CI_END="6.6680942055256285" CI_START="-3.4680942055256327" EFFECT_SIZE="1.5999999999999979" ESTIMABLE="YES" MEAN_1="26.7" MEAN_2="25.1" MODIFIED="2008-08-08 11:21:32 +1000" MODIFIED_BY="[Empty name]" ORDER="27" SD_1="23.9" SD_2="28.5" SE="2.5858098646210395" STUDY_ID="STD-Fagon-2000" TOTAL_1="204" TOTAL_2="209" WEIGHT="4.470383490102857"/>
<CONT_DATA CI_END="7.434640573240407" CI_START="-7.434640573240407" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="21.0" MEAN_2="21.0" MODIFIED="2008-08-08 11:22:02 +1000" MODIFIED_BY="[Empty name]" ORDER="28" SD_1="15.0" SD_2="18.0" SE="3.7932536678652786" STUDY_ID="STD-Ruiz--2000" TOTAL_1="37" TOTAL_2="39" WEIGHT="2.077371568628048"/>
<CONT_DATA CI_END="11.61015465436715" CI_START="-7.61015465436715" EFFECT_SIZE="2.0" ESTIMABLE="YES" MEAN_1="28.0" MEAN_2="26.0" MODIFIED="2008-08-08 11:22:22 +1000" MODIFIED_BY="[Empty name]" ORDER="29" SD_1="17.0" SD_2="18.0" SE="4.903230227785216" STUDY_ID="STD-Sanchez_x002d_Nieto-1998" TOTAL_1="24" TOTAL_2="27" WEIGHT="1.2432927034427603"/>
<CONT_DATA CI_END="2.4957184304070257" CI_START="-0.09571843040701977" EFFECT_SIZE="1.2000000000000028" ESTIMABLE="YES" MEAN_1="23.6" MEAN_2="22.4" MODIFIED="2008-08-08 11:21:22 +1000" MODIFIED_BY="[Empty name]" ORDER="30" SD_1="3.1" SD_2="3.1" SE="0.6610929795789536" STUDY_ID="STD-Sol_x00e9_-Viol_x00e1_n-2000" TOTAL_1="45" TOTAL_2="43" WEIGHT="68.39319083116173"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2014-10-03 19:01:01 +1000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Invasive quantitative versus non-invasive quantitative</NAME>
<DICH_OUTCOME CHI2="2.5873650612963464" CI_END="2.4138257211375898" CI_START="0.5408220345595127" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1425629687582712" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="25" I2="61.35064143213829" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.38270591071553467" LOG_CI_START="-0.2669456223684519" LOG_EFFECT_SIZE="0.05788014417354141" METHOD="MH" MODIFIED="2014-10-03 19:01:01 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.10771979025921918" P_Q="1.0" P_Z="0.7269071813226741" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.18205379119975684" TOTALS="YES" TOTAL_1="61" TOTAL_2="66" WEIGHT="100.0" Z="0.3492426084537884">
<NAME>Mortality</NAME>
<GROUP_LABEL_1>Invasive</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-invasive</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours invasive</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-invasive</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3988277881586868" CI_START="0.48047696983065397" EFFECT_SIZE="0.8198198198198198" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="18" LOG_CI_END="0.14576425112084268" LOG_CI_START="-0.3183274240519704" LOG_EFFECT_SIZE="-0.08628158646556386" ORDER="1095" O_E="0.0" SE="0.2726097472873527" STUDY_ID="STD-Ruiz--2000" TOTAL_1="37" TOTAL_2="39" VAR="0.07431607431607432" WEIGHT="56.802724102544595"/>
<DICH_DATA CI_END="3.8250149783694636" CI_START="0.8170736311425607" EFFECT_SIZE="1.7678571428571428" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.5826331401459683" LOG_CI_START="-0.08773880496326922" LOG_EFFECT_SIZE="0.2474471675913495" ORDER="1094" O_E="0.0" SE="0.39377979895181275" STUDY_ID="STD-Sanchez_x002d_Nieto-1998" TOTAL_1="24" TOTAL_2="27" VAR="0.15506253006253007" WEIGHT="43.19727589745541"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2014-10-03 19:02:59 +1000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2014-10-03 19:02:59 +1000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAADnCAMAAAD7EqYIAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2014-10-03 19:02:59 +1000" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAATwAAAGwCAIAAAC7FU7yAAATGUlEQVR42u3dP48cRRPH8ZWQEMEF
DvwKeA0XoRMRRM97wuEFlnDod4F4CQhDCI7IEHBG+AIHNmT8seZZcxI63c3Mzu529XZNf366wOwd
dXM99e2q6unp2myIKJ0GIkoi0BKBlohAS0SgJQItEYGWiEBLBFoiAi0RgZZO5Fi23IEWAO3frNGL
5Gag7ev2JAJg/sJ4GmjXf28AQKCl2jMOBwMtADa5LlheANquic0CAGhBC1rQEmhBW8WxEAvarm8S
AAi0RKAluuNYdjKCFgBZdjLe/gcHA213dygdAFaPQQvaZACAFrSgzQeAbYygxS0ACLREoCX6b7XM
Ix/QAgAABFoi0BLddSypAWgBkOt5z8wnBNqVV7a5AAAtaEGbD4DbF8nBQNs1t43frM203EfQdlfK
AoBASwRaIgItEYGWCLREU45l8Qy0AMh1RhSBttM75JoJtABw2aAlAMzm83wMtF0XtO4Xl+AERKAl
jiU1AK2b5CV4Am2aO5QOgNBrFsNBC9o01zzqqx06MGi7hjYuahW3PG+kKx8Gbac1ragFWsodvRNF
LZ2NQEvliYrbEKKJJmi7BiBj1AItaE0KIQDELZ6BFrQp68+WAahwguRta2paavLeJKwPeRRoRdrY
24800BIFdkXwoiJouwYgex2upqW+AIiLWlaPQQvafFGrwoNl0FLzNwkA965WekydxnALyKCllNwG
pcfmAtB2nR5nzGBLxfAKO7FBS/0msRJv0II2WdQCLWhBmw+ARAfZgJYyAZB3Cpv5BLRkOmgILdCC
VuJdGIA679P2TCxoM4XBjDuEE40GaClfsOUGoKV+Y/hgRxRo3SQ7ogi0+TJYO6IqJyCgJdC2juuS
D0FLolaBgrzUCB/wXdBS7rSt5hTGHwyE6SCHJ0QfKNt4YgxaxKbcAhHkronKENAmK2vb9/77xkOP
j+zwdULQZiI2goE6MdyKN2hBmyNqJYJ2yNMkBbRdR9pwx/ISPGi75dZ+wNQxHLTUb9TK2CQFtF1H
lbLOmnq5qPg1J2rtBdo0ifH8h/2kmpqkgHbgpj3Xh6Cl3qeD1IfC2MZICvKSAVxbENBSJWIl3qCl
YlCt45zHDlt7gZZUyyItBQPQ8w5hvgralPWhqJUlOwAtaDNFraCTnLyZBNreuXXBoKUaIav9ZlZ5
s4MU8w5oBfChc27TVfigBW15HkIrT4tnoM2XIaewTKAVDyvVdUYDtNSpm0Y88vFsGbSgjWqiGXcK
BF8Fbdc1bejhrNGWi2OcKIyDVgzPAW3lhiMtn18BWtDG9i7I0spkKoaDlvZ2o+jY4pEPaImqVvjR
UxhoqVgEkNJ3OxSgzRRSPPNM2tkItL1HWqMxhC2eeWGA0DVE7JeOsJyIAtCmzJOLWx4id0QNTp8C
bc8JYbc7oqLbkSXiFrT9VnHpLEe3I1PTUr/QDpGNsG0IAW0ybgFA7hZhQFsQigmzKaOBMA5a3KZI
vDNuNnTuMQWGrG5Xj2uOsPSYmo4tGdelK7QFkR5TR9BmTLxBSyH52xDzzDOR19aZaEBLHdWHqVN6
NS2166Zx+3jrHJETkXjny7yw0VtsCd3HS6B1k/TymcwCOjzmDrSUY6KJfppqcwVJ6UMAqH/uMWip
TJDpOYl1zaDNF7XSXXZoHa6mpY6gjYgt1SpP5x6Dti9unXsMWqpa0Ha4Rb4OtNJjonBuQzceW4ii
HGHcXABaKonW0OvLaPW5lR5Ti1Vc6H0vPtFUWJfOsjgH2n6hjeO22jV75EPdRdq8p0/1zC1oM9W0
6d7FyQVt3AkhoKWuJ5oK79Y3HsNBC61Nz1sCQUvhIavsG6pZ3BS0oM3qT0PMSVHWeHOtHYA2E7G3
P2kZWmu8oAVtCLRD/KJOImgdVk7haVvjd63C6vEQ8Ho9aImi4qHDykErhnsJXk1LCavl9qeDXP0W
QEtpoK05HRS0ueRD0NI6uc17gqTntFTYmYZUx5G6caDtPRgmegk+umte50fkgBa08nnQUhJoMzLA
V0GbrKaNzjNTJLHcFbQUnh2kWDxL1HIBtKQOHzHe8o4r0CYr5HI1aM614j36CWipmDMlCrYp3sUB
LfUObay/VuxPC1oq5kxBDBjtNP5gIHqO4bk2SJIBBW3WLkHd5h2gTVnIdQttXIXvjCgKdNOgYJt6
jRe01Au0ebODiPFxsBv1y23GmtbBbjSkcCY95hO7hIHoOYB76Q+01Du00dlB2anhv0RDekzlM+Sg
YJjoDGGbOkEriU32nnrNRz4iLXUUD4eKp8YFJfPSY+ouic3bcER6TO0msUPC1s92RIFWDE/juBWS
WDuiqGtoMy5xqWkpgTPpBJ/YJQxE3vDYW+Xp9XrQ4jZxtRz6EjxoqUVPTZd4x42GzRU0pOBqBVkA
aEnELmCz5hpvupQetNQit0mXi9S0FMvA8XetQlsQAq142PvbAoniIWgRO+B2yLmLC7SgzbHZMN1p
jBaiKEFCmDGGgxa0YnjKxLvzFxVBC9rYxDvpXNBycQvaTOnxkGS3bdIjcpL5g4FoPx5mPDMRtKAF
LWhTZjSgBW27B39HJ94mGtAmq2k98hkc3Q5aMTwXtBUaYYOWeozhQ851adsYKSS8OCMqSzwELWK1
yapd4Tc77YIWtOHcJjoEPMUdBC1ow0vlsi/uxyXe0W8mgba7GqbbEi56Ikg37YLWdBAbCctGxaS+
WnbaBa3EO9BB5z8k0FJDUavCE+BuiwXQ4jblBSd9FaHILAZaBW3XizoVYvidS1XTdkqX1CDR3mOr
xzJYA5JsVzNoQZsAADF8xrj0GLclzYbuLkq3kav16wRGhzVt9Lb+mSBWcCLwlg91lB7XP/i7/fAV
McLFJxrQqmnrHWSTKEMWaaldbmtOB0X+kDq5cctcgDZfQes5bdyMFjTCIY2FsdGh66feERVRh2dZ
pQctVUoQIhjo88Qs0GatDxuPWjWLhSOHpULeUXaiAW2PVVz0M08eFTrOoO0R2gpo5X3pr/0/AbSc
qVKEabZaTrfXCrT91rRDwpf+au4Pa90fgNFzDM/Vr92NAy1oh7IHBQ4VV2LjZoSWLxi0ySrDlg/R
PtWwtL92EFLUICRLTlj89t/2g57T40S9C0Cbz00TvJ+d8wmwl+CpR2hrZge9103YSFTFtY9WxjZZ
de7gYBsjNYtW0uygwrnHgxcGqE20MgbDsmiBVnpcY0tgz8UCaCkwHhqN0JQ+tOGIkytA2112IKUH
be/cpt5p2G0mAtp8Iav9qGULRGjeAVoBPCrVTD0ttryLC7SgDYm0jn0FrQzZI58RBjJeM2g7mqcT
vaqeN6UvuyPKwW6gTfDWa/RL8Emf00qPQdvdUWYVUvoKO6JKTTSgTcatm2VyBC0FhkExfLB6TNDy
MAm0ORw0dObOmMTmnSJB24uD3l6VDfWtshNNll3NdzpfN77cDdo00Ib6a4SPJjpGOOiapyxYiOoo
0gaxWqGnY8sbJEFLCaCNK5IrRNpq4wxaEmm7g1ZN2yO0FR7MFK9pg645dDTumGr8rQzQ0hDhqRQ+
mxsIItASEWiJCLREoCUi0K5+9In2eZQF2hNDyzLL+1oGLWhZBi1xU5ZBC1qWWQYtaFkGLXFTlkEL
2td/v768urx4fvHgmwebrzZnz87Ovzt/9POjV3+9atby369fX11ePr+4+ObBg682m2dnZ9+dn//8
6NFfr151OBoRlkHbLrRPf3v68NuH2zt9/2vrAU9+fdKg5d+ePv324cMxw5stw78+edLVaARZBm2j
0G4n49Gbfftr+zNNWd6G012GN9uf6WQ04iyDtkVotzP0zvt98zU1W9e3vI2xywxvpuLtmkYjznLT
0M5s5trrW/MbxJZuGbt3qNIxH87fmG0VNJVTjWZZ139en9zyto6dyopH8+Q/r69XPBpxlpuGduao
nsO+tfOTqSng/r+P/HDnjbm8ulx4v2dSrMqWry4v9zE8niSvZjTiLLcL7Qxdh31ryX/uXFQ4Etrl
kfbi+cXIrb3R2C0//+785JafX1zsBe135+crHo04y5mgPfJbC6Fd+L/vC+2+6fHNs4Hlt/zs2dnJ
Ld883Vn+9ezsbMWjEWcZtPtVtoflzPNRd/zD0Zt9W/fu+skt33fFhzsMr3k04iyDdnOY8eiaVqQV
adW0x0K7ZLmrILRqWjWt1ePDV4+X/19Wj60ed716XPY57U5s5heKlj/d9ZzWc9qun9N2Ijui1joa
ne6I6hnawd7j/KNh73F30N7M1uPrkP/mVI9fPG7Q8jbeTq0kbz9/8fhxV6MRZBm07UI7TL+NOVoF
NWJ56n3a0Tp29aMRYRm0TUPLMsugBS3LoCXOxDJoQcsyy6AFLcugJc7EMmj7hJZI1zyRlmWRlkDL
MmiJm7IMWtCyDFoCLcugJW7KMmhXDq2ueXUs65pHZaDVNa+OZV3zqAy0Tq6oY9nJFVQGWmdE1bHs
jKgaLr5kk1fQLy344fyNcRpjHctOY8y91rrkN+qaN2M57txjJyqvE9qZEDfs6tmzs0dWfWh1GKhj
WYeBk0E7T8tUC6zlPbLqQ6uXTx3LevnUrmmrcTX/YxHQ6ppXx7KueU2kx+uAVqQVabtOj4tAq2ue
mlZNGwLtaKQ9LPzO/1Krx1aPrR6XSY9HF4oXrh7P8Klrnue0ntO2gnrL12ZHVB3LdkRlWmduf0Kx
97iOZXuPqWQWoGteHcu65lHJ1F3XvDqWdc2j09fbLK/YMmhByzJoiZuyDFrQsswyaEHLMmiJm7IM
2h6gJdI1T6RlWaQl0LIMWuKmLIMWtCyDlkDLMmiJm7IM2pVDq2teHctv375+8+by+vrixYsHv/yy
ubo6e/ny/PXrR2/f6ppH+9xyXfPqWP7jj6cvXjzcsnr/a8vw77/rmkfLboyTK+pY3obTUVxvf21/
pqlxBm2L0Dojqo7lbYzdSezN11S8dUbU4a6/V0O9vf5eXfOWWM54GuO2jr2dFX/99ebjjzcffPDu
63//23z//d08+Z9/nMYYGa9K/UW65i20nPHc4zdvLm9j+eGH70D48svNF1+8+8dHHy1Kkp17XB7a
GZb27Xara96M5YwdBq6vL0Yz4R9/fDce779/9/OXL3UYODW0+4ZlXfNmLGfs5XPzdOfO1w8/bD75
5N14fP753W9dXenlU6WmLQWtrnnzljN2zRsNs59++s7mZ5+NL0edfJzXGWkPbpbVDrQi7Qkj7Xvv
vRuMn34aIVakDUyPlwN2ALFq2tXXtFNfatra0E711Dtyadrq8WpWj2++brR8i4XV45BHPvfb5y1f
PdY1b6HlFTynnYfWc1racWPsiKpj2Y4oKgbtYO9xLcv2HlMxaAdd82pZ/vctnwfTb/nomkeLb/mg
a14ty1Pv047WsScfZ9A2DS3LLIMWtCyDljgTy6AFLcssgxa0LIOWOBPLoO0TWiJd80RalkVaAi3L
oCVuyjJoQcsyaAm0LIOWuCnLoF05tLrm1bGsax6VgVbXvDqWdc2jMtA6uaKOZSdXUBlonRFVx/LK
z4jaq+1NtQp+YUOQI3/76G9xGuOdalPXvArjvAe0hzW/qQPtkY15jvwVzj2+ka55dca5DLRT7XOm
Ys7CH7tzyPhUvLpzoPEMMKM2dwbD+/YHHQZ0zTvdOB8O7U73nTnLf/mR/0tC6BJoD/juXnNWcWj1
8qljef1d85Ycxr/QfQ/z8nmnX/KP4tBOzTs7exHs+KN0zatiua+ueaNOWQra+Y6VO3/XFEVT/+MB
0A5jrUaG6f4jIq2ueSeItDOhJi7SLrz6JdDumxccdgFqWl3z2q1pFxaox2StCx/ezKx15a1prR6f
ZPV4hV3zpmra5Tnhkh7th60eL4lyo6XmkrLTc9pOntPqmkdHPay2I6qOZV3zqBi0g73HtSzbe0zF
oB10zatlWdc8KgbtoGteLcu65lExaFlmGbSgZRm0xJlYBi1oWWYZtKBlGbTEmVgGbZ/QEumaJ9Ky
LNISaFkGLXFTlkELWpZBS6BlGbTETVkG7cqhzdg1L1cHuozXDNp2oc3YNS9dB7pB1zwqBW3Gkysy
ngLh5Ire65BSV5LxjKiM5y05I2raeqEeX0t6+RxmecmfUPDD+YvJeBpjxg50K++aVySMHN97cskR
qmXj6pFHHPdz7nHGDnQr75pXHNqZxh/DgjZ282zsZXmqed/Mr9Y17/6HGTvQrbxrXtmC7Zgj/4s3
yJvqjXBCaDP28snYgW79XfMK1rSngnY5gQsnmiBoM3bNy9iBrq+ueUcG3p3gzS9fLW8kPZMetwzt
aiJt4x3oVt41r2xNuzxazpg9gJzDuBp0gj+iPmy5A93Ku+adCtoDujwvsbxXpD2mHXa3q8cpOtCt
v2te2ee0B68eF1mX3quEnirLPaedeeaZogOdrnlUcoHdjijXDNpk0A72Hrtm0KaDdsjZNS9dB7pB
1zwqCO2Qs2terg50Ga8ZtE1DyzLLoAUty6AlzsQyaEHLMsugBS3LoCXOxDJo+4SWSNc8oj7megNB
BFoiAi0RgZYItEQEWiICLVF6aIkokf4PZxwRar41UfcAAAAASUVORK5CYII=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2014-10-03 19:02:59 +1000" MODIFIED_BY="[Empty name]" NO="3" REF_ID="CMP-001.01" SETTINGS="SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Quantitative versus qualitative culture, outcome: 1.1 Mortality.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA1gAAACwCAMAAAAlvj/oAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2014-10-03 19:02:59 +1000" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-001.02" SETTINGS="SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Quantitative versus qualitative culture, outcome: 1.2 Antibiotic change.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA2kAAACgCAMAAAChWdR1AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2014-10-03 19:02:59 +1000" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-001.03" SETTINGS="SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Quantitative versus qualitative culture, outcome: 1.3 Duration on mechanical ventilation (days).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA2UAAACQCAMAAAC/HzNWAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2014-10-03 19:02:59 +1000" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-001.04" SETTINGS="SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Quantitative versus qualitative culture, outcome: 1.4 ICU stay (days).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA2UAAACgCAMAAAC7ZTT7AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD/gADAwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID///8AAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///9BjlLGAAAgvklEQVR42u19fXAcx3XnWwAzs7MLAujFwiFjKwYJhKmybDqmaIDg
gnLdkraiMCnmQ05STuzo/IflilVRXYV1l0vqSnZSV4ld5ftI+SN2XZWi0jmxK7ZjKaYjWyYSCViI
WtNQykkusbIgaDkmFAGYAUgsFrsDYK+n53t2dmdmMcvdBd+PBKZn+nX369f9ul/39MPECCAQiJai
B0WAQKCWIRCoZQgEoou0LJ3kheRIvUgRIJuF2YT1JMGeNAYlSCeaYiYh8Mm0R3ZqjqL5YDYgE7OJ
1sktm83mIZ1twAaN4+NPMEaIICTUn47ul5RfxbdGQjzFapSK86L6g1oWBCO3914b2PtFxTv2xBTA
zAw8ftp6cpo98cWJ000wo9yqbhZ3b3voPC1S5UXH4wGZePx0S2X3AHyxMcHMa31PpVVONzPL/6b+
dPoE8Dzs+NRoufenZ1mNzrz2o80zxR+hlgXB65lkakUsEDY30B9FFOggRUMkKZQ4+ogGefUykuT5
+CwLZrlskiZNZsklXqhKajbSAC8kFCMTAI0uq89DiQRIVYEfkHyYGZqWOK4/87qRkpWZ1kZRlmM+
wXOJkpa5oDMxMiDwlzQmaBl0Wq7DRL8IkslvFJiX4Bfm9brTqmm80YJSCeEJnSQVB/UJdxYeOkx/
UpLGqyYRI8zopWqcTy4bebUJ878EO6xGmpwcfcGo0bPwM2prTNMaTcMDKb1d7W2s09P6cUklYpl3
qZYJ8ApAwRrCBqRycWqLBvYSmcfoDKfOGBX1srla+cGZ8ywIZ+cnl0GZfMveQn/i3KiabPRUcuD0
IStbjc7A2gaMnktsnDrqw8wO7ZOUn0eM+02BlnnbluO71ipbp4mWeebFSYUy8WL51OX+BZYzLaM4
uVmPiZUfwVGT3yhQegQUtfMdPZVMnhrVeaP3u4uZDxs0rzDJqnJkzBw99ZzG69oPqch0vhn96Dmx
OHnMyKtN6PsAvK9PrZEmJ6sviJnHDJp7WY0qRo3MdrW3MaOn9RuaHFTzeu7c6F2uZdNA7ewU7Jld
556BR9nd0go86ehT9wx8EKr6jQifhGG4bxsKi6rAAcqwuDKzXbc/cvBOWCxRqsbIaMyY5ZZ6bGWy
B9cuDcCuOUAM039CBQYKwIqmZXAzpbpMpMDiNwqQwkiG8ktzXSxQ1k3elo5YPKcc7FMBxDVeS8Ng
8s3odd71vNoE7v+lCxyrEZMTbfJDWl9YtdrEVSOzXe1tzOgrcHJlZkvN663RybxLtSwHdDaXIGYa
bSf+8KtU9VRpOlubnNj7DotQsTj/J/nt3MUqPPSQ1umZftQFjZtVSfeCMVP1LFPFtx//bD+c1W+u
58pKOXd9F373Ie1B1Y8Ji98osAKv0396rlcs3lJg8WyTrArGa1WjMflm9CbvLK824ZtUJ8wa7dK+
sHuopi+4amS2a8oZzsAZrUbRyrxLtYyDf4L+ceilIlK7OGzB+7/vSbgJr75i9Vhh+l3T8VQMvjwz
o5j6oV7Ato8yp2WpV5qS+g1pfTAOyX+iPOn5FO1lqrgAP7S4S8UzQ5l4qlfNmc2S81pxtNi8vRtY
TFj8RiK6nDDPGblWnLwZOE4la0OvTQoW3zbeIYiYWoaJ+UqOs+S05V2jPmdnthh2trFeo2hl3qVa
9q+5dytf+2mI00YfUa3nh+H4mBU7biiPRON/aoF1YfZkaXZqbommGlvOsu1pFhKpSJfThoapg17a
XInxcEzJ+u1kJ8Ynl7nH4W+MfHrg0IKLl/KYpdOruUl+lea8MMI2QmhoTKFM9MDIeWtu1OsFJpfR
baf3Tfdqliuru86bA9IKnR9ssHh1hk3e40Ze7cHHpz9hk9PD8FO1NdoG0Vkjq12dbczql4ha5t2p
ZUcGepMXrtK5Q56//Q16P5V7u21D6Mtz96iX5NwbIZHbeJYGPzf3JjaPPAZ8CpauFUdf+jumdSeL
b776PMi5D3JaSpXuT3ObnJHTjWv3JfMbfjbYXz0/unV1btHIJ5FLPuvgJTk+uqvzo04m2zDLwY0r
FzZeWtfKKCbztyARuy1oSVQ6vV4MFr+R4H8Aq94Nre7ruVG3YZQ9LL7/rP2BxaszbPKuy7FdeBw+
apPTVO6Ee3Mwe2Tn71cdNbK1q7ONWf02tLw27nxVYp13Wrg0stk5zKRLRUAgDpyWIRAHDHiOEYFA
LUMgUMsQCARqGQKBWoZA3DVaJvUL/Llk3u47paKBi0++eo4XkkoAyoDw95NqBGWA5/n+EdOXyrsA
W+42vzN3kf7+TXVhyJGxQZrlgRYvCVleAiUr1MTroRq/uWw2nlVddUaycVtZ3g1jPpSSAj+g0HIY
LeGHAPr1A5izCV7oVyJo2Ga6gphVe9ac8V48SFWUfnbmPq/RDgq0KlW9KmmR5y+1pyoOLXtq4lDl
65P3232nfPAfzv3fyvrkRyJlyNdPqj7IqWLlyoT6sk3zpfKA6ghmOYM19jvz9W+qA0OOKhs97yg1
y8MOHM/A9HF65WwJHfBIK7LDsGWIW6XN+Li/PTW53n8qTcvJq7RbxV8BZVfr2enzsdeSEwNtmgB4
UJvwZ1WfoaBVGZ64kjhH4GfgokpbHtgGRdSqMnKr97WNhaH2z2X/mQpanNnmbI5QSlIdjEU6Pira
6HhJEAZA849Shw54C03xecuJavBBUYF8Ij5keHLBgMAPguVX9YTq+NUIAfyk6qJCm+Wsdg4+FYet
RqSsHszlS/db8uDE37/JG7ocGRtJSDfLA5U5zNKfEeBMXylDtuosI2j+dS68zk7Wl2HFOdYrvAiS
yKd1PzKtXU1+xQJN8WOaNle5J2FYnz23M+spaabUpq75HDtSX6FXR1XSAq1Kglf0dpHEB62qbMPZ
RaqXu9qpkb2VXRjWh5vSdDwlzhTbr2U9cFKc1fyPjEd9kwlJHVQUeApUyQ8uJC6folqj+keBesb0
HWoKC9WrU5+Bd57+ujYJrP0QBk9dTt5nG0EeS57ua8hPED+peuiD+0SjU7/S8Oi1Vg/mk2T6LdXk
FsC/qY5IT5pS+T78erM87FJlFejPLrxu+cOZsr2wmHm302VNA3c1MwulzFXO9VicIsem4qu6H5nW
rkajqQcxq7ScrQ9R6/9haqmWr2sx74PbbVzMTLx0ZhbSZ65OOB+vxqe+fey0yOnt8tTUVaulY2pV
rsAfwHsFWsGe5R6poldFgVc6Y112ax6mHk/m7bECFL4D8BodUB5lE/c2LA5oDjxs5H3eneLGIjxD
jZUBWdOYYUo7sAi2wfBGAYTGVl8AP6l62BBg6kS/NlemGpKb9QDLb6mmvwbwb/KEXY6p+rRlBw+P
unmITeUruVfnlPxUjLP84UzZ3jhSx3Xn03CBTkv/074KVC9LwtZ98982/Mi0djUts6dFNbPc5tTk
78B9SfFo/BjPRsZCQ++dloODacorX1OV+Z/bml8y2uUZWLxhSzH+NL38fu7TidP3QHxUPMb/pVaV
TFurYtMy7ubCPEy+yx47DSk6koi5neWd+RU27NH7XdZ72Ghz87vOFKkUNXL2YILTuxilnXDUjhLE
GvITxE+qbqt8YSEHE9rMKTUsx6wHWH5LbgTxb/JmwyZHKSAPuh+dDVfhxbN9qb7pLA1Z/nB22XrL
42Lu16Ty3AfBvphR6eczVWHC8CPT2lWHnH8kPdcDxTJ3ET4Lj1SuV1a3f8AM3hxI7dSy63OipMxd
r6lK/Mw0nzLapar2KQOvXix+JAewWeYWqRWwXr5euvHbdJ3Z9qrYd/JT6zdf1ttd96maA0lljpv+
yWk2pDys3p+3pdi4uUBb3vTdktTO3QuSufbq1R6ZflV5v7oG8ZOqi9T68oLuCuvypXLBVo+teiUE
8W+qx4Ypx0PQwEC28VDrR8fR9RJPJx2F/rZ8peyyrVN4X+EnMn1czf5rOTdfUgw/Mr1d9ZI2K8VY
r9Udnt7izhzZ03g41E4tS/FnRjNczRyUL83PlRWjXXL2qqQeK29VOWMUA1gQUhnuSa0qxztDy+LZ
VOoZ5rwoGT5VZRgfpZdvwASwbvAlGFuAeVuKUuqvaYqHIT3KHhwdo9UpwUKfZY0sjFn+YgDnx30s
xgB+UnUhUnb6NAvD7Uvlgl4P1e/My29Jg79/kzcMOapsEFitS2bn4XhN3v9MZ8wCzSVDhWf5SlHZ
Dls0c14D9CptrHjNq4nhM8mvT3/G8CPT21WjEYXlVGYNRP6lMdY4v7UDuRHWL/51bkh6Idu+PynH
wSm2PeSsyvnMt5KZPqNdOBg7alYlwSsvTAu0RmmReZ79vADj2qgkjm9LJcuDrn1advulIv/R/N8x
3yndp2rn6ub/VjvEHMwfYSbxteKFa5Z/zgv5n+PO59dhKrepWc+9W/MzIL/4SaJOb2z5cO1C8dq6
5VfVs/nSWmOGfP2kGiyI3jrI3zqpeknV+FK5oNdD9Tvz8FvS4evfVAeGHFU2zr4sBuLh7TV5H6Ey
H4YVqoav2HylqGx7DNma/nWu/aMY5ApMBe0blqeuSud/8um07kemt6tGk4yNblE2+7mzW9foEme2
hwNxg23NHbmy92Mfu9K+Pym3OAdzi5plZa/K/P3yi+fm9HaZeXErBgbNN3sTf/SyBM/33ho8uQSQ
7llR15lsJfLV3cOD19bbVJEgni8S/PiZ760Gf8+RuF743Ze8Nk2zMAOI/YDK9tADV7cCUKaLpUho
OgAjt7cjoWkfgmiZUO1JhFg7zr5nF7jEilcfgQoqyr5QX7ZuJFfFSGg6AElxNRKaztYyBAKBQNzd
+OUO568P5zJE96PDezF6viAQqGUIBGoZAoFALUMg2gvnTr5srCNdAdlcY8rWSlMPel72DZk42PDL
VybOqxWol8DNdd3sw3ASjmubbEk9nq2GIC7GiVcCe/MQV0MSHwpP1tlF7ujdBe0s0mAna1mfu5Mw
0bsDZovKVtvqQc/L/pXMyY9fvrLragUaqIOdXRIJJ+G4tmSrJZTr09hqaDIuEw8lszWP+wHxpfBg
XbsQGRBRWYxaf5O9Am6KRh0zCiUjrpxIEPIGDxrw6KO/ITiR3VQkIA9yOFmS4BIMWSiJshHvLLLd
omUu+ZJ6Em/YAnIU4x5pjtzsOMHTa+zKdbkmzXAdUgYy8R0ZbJGyHGQoIVHLuNPR0Sdk+5ox5hos
fnQrIzJYxkzE3ULLT2c3iJ1rEfiu+YhtFUV8eQg3K2mZU3uC/m9OJo3Zb5nA72aE1zLScNHTspYh
YfQgcH6kFUyToFyToKpbY4vah4gmhseIBI5o2mKUIehWwh1ohXBFyDLIreck6mobmxFy3f0Pz8jQ
bBDib5l2o2YNDg7+4uBg12gZ29ZgI3xNwE1xp5VMDtqNAvIkN7iLTsnkELF1mNdKC1GzyOxFRIss
RmIYFbUBN4XaDiysP3FeIls7ybrlEibfIGoQlmuLE9nX8tJz8+U6SJ2cpdmz1Bdn9YquV4ZVEa8k
NQKPtj3vWqB/2V0CmewjutPtyGyH++DjCau7Rs3akhRRYzEiDi7IPqLR3sG5DIFALUMgUMsQCARq
GQLR1bDvfsjBVrot9SvzLMOXtRomArwAcxVAfAnB9228FxuBuQ7qQdfQv8zxWtklwRr/Ms2vxSFZ
twS1WDzSGKGWBZNlS/3KPMsAq6MHJPdlx51C9iF0dsSgbPjrTWAJBvMvs52Kq8m1xr/MUjC5prZO
57fO9y/b6Gw3zr5GYyyRTe9o2RzQ7sSwRjyCDboggbCckZCE9gNWcuBM5dbsjzfyhpN96EiDadJN
QQJUou1gFf5Kj92fvyu0zDZc2oY3uS1ntGUI+icG9jl3yv6N2cQgE5kdbWNQbmC5Ek/R+eQpe6eS
gXSBkmlMZv+qs1/q9dV2CtfhYK8GvAM1ksP5dhjn8AIYdmErYRiMckBnMNvZPxLcowUCHrEI6l9W
V3Syj7u39Qcnuuh8fmcfyfdcl3WOFR7aucNYxoVbS/h3JxJyfLBWk4FZb8RyE/5lpN7EShr5Znfx
nyToGi1z7TztexbY71QWvEx3NAlXgNxok5FEqa71yYmP6VkrETnsEOSZ54HzN+tA9NRfUtbTtXYo
WUB7Mbjt5ezgDdy33FmHGhrCKXoDBYnMv0xuQZ6IJuYy3XaxLp4eSq30K3OVIZOw5L7sOFNExElI
NjwF6aeWjf3Lauhqcq1XEZk4Y9GxLErE0F64O4D+ZZ01l9lsC1Syu0bNgpmZiIi1DDXsQAH9yzrW
YkQgOhwbjrsOfW+GZ/IRCNQyBOLAa5m8j1gEAgG15xjdHwWR7Qez7c4W9lh7BtG4noV3GHMRhTul
2GA/1aMSAb+NFpwNua6YDOeUGke7KPzL/L5fZhaM/mURapmX4jQ+ueRxDCoS17PwDmMuIjmEOgP4
fPfPVQk5ajbk+jXUFaXG0S4K/7KG3y+zfbgQv1/WGovR+tCQETL+dLfsESubH/uJbMTzdBgLcaR3
P+cJA3DSCjZIYOb8v7YGoQ9y7leCiOAWo2GNNJxCamPviJOE3BInTf3IrRw+SXRsNM6wvpL5+Jft
kzk8YdUiLSMhj3t4fZMvMnVzOYwF0+RmFxC+X6aFkF+hIC0eR4J8v6y5ppADusYhmp3LatdlstWs
xPNb4S0Gqf3kbCDycF2KNNELI2PD9gHREKla/f0yVLCW7n6EELaHI1rEU1nLIQf6sqbTUIuaOTnA
ROppMMrhJEg6SO64++E9YRFP+bdWyeTQ3TXsVKn5WMkhlMzfLUuOnIc7N0zh98vu2LrM8i3y8jJy
xDrH08hcz8I7jNk4C9+/GuRufNHL/dmvyNloWEOPLH38y+o50NX7whl+v6yVwNPCdwnQv6yjLUbE
AVGztiRFuC1GxAEG+pfhXIZAoJYhEAjUMgQCtQyBQC1DIBCoZQgEahkCgUAtQyBQyxAI1DIEAoFa
hkCgliEQqGUIBAK1DIFALUMgEKhliAOHueXO5q9XxDZCdDtO/3C+o/nDv/uB6H709Za7xWLMMhh3
6YQtgl1ScVD6eaEqQV6jHBSGAKolnV7k+UuKShvvAsUlgiCm1UCC1U0Rsu3iYSTB8/0KwBNxPp52
Eqi8KZdodB6kfoGvKurDfP85Vc5M9pdKdnI7DWsLxWxQo12VKi/0Szp9kj3LW1WfTfJ8Mu+gk/is
lbpzUVWUbrEYl5aOwsySOQm/yQweBTUo3fyXMnnnE18+80jsK4cvfnZpCWIDWztKMsZoRm5xP/pv
h9YUSpsov/7xDm+V0v3/8IbtnR1QDp1mdUtNwtKd50ESKQ97ez944uSaUip979//1669ryj9U5Qp
EpO+dv2/xv747KpwZl0dsD9/9ve+ButlJvvvOTL88U2D5i8m/iFdXS9Xjl+5sbSktaD2R57+i7jG
nbpUYQ0W0+r8pdNm1b+4U1x+6b8rdrrPqrFLR++8dELOFWtv2u6y3Y9LgjAAPB3CQBEFXkzpj48V
emEbzi7Cz8IufFR9sreyC8Nxvc9Mx1PiTFENXj4z1ulT2XBOXCnTieABvUOX28KDpPKwXT7yfVAg
PSceKW/Z4x9gw1cFCidBpDK/XgCmHSKcXKQhJnvBkeGzJk0FxAKU4XDNn8X5FCwuwlkWfNuuVvWK
Te8rnACKnW4k0x0W4+pw11iMOgYXEpdPDVLhz8CAVC5OGU2vQAFiQM2IK/AH8F4hIUHPco9UuW7E
vmJk8BYod3qr7P5m8kPJNWou/Ru7/UyiXTywPn2MtsLOwwle5chCnn2XvAqpFHyAypxequqDD2gh
u+x13GPSPAzMKtyBEp90mFIst3tY8OJNbUXzLUcex2haG93rV7tkYbamdJmWlWFxQNeT0j0Dj8Ke
qWUp4GD8aRr8/dynE6fvgfioeIz/S35Ijc1AytxQgd1Ob5RMQZiafDPAJmM6/azULh5U2c1u0Qkq
U1jbmPyYPX6T0+RK8SRMa32foqCFmOzHNNnrKJg0cRgfV0Oxzf7J33GUqf76MxZ8jFV95MP32+Mp
K1M2OiXRNX+Jca/LtIyOYxO6ngyd+MOvag3MlAfg1YvFj+RoByhzi3SkXC9fL9347eKvqLE5MHuq
PqB2NgoXwbSVtn+vnTyMnJteUDtzqQR/WkuT05pkzmgBI8Rkv6XJXodF88n87XIuBsUrXMGZZ86d
ffErDiU7P/3yf7TRDSW7RMfSEO8yLQOQJDjPAlvw/u/btE+C1GPlrSpn3AMsCKkM96R6x8FxM7nW
1J0Mq0OqmHhc3UhrCw89IN3qubyu9+uYV/tIefrrnNooLLpXDTHjzpS9DkqjaDTcplKs9lqDI4O6
UxhTE5+zpTl9wlZ15d3V78l6IkY3eaIdgmkCVXUfoau0LA5jCzBPO4FEbfTj1kaGWo8Er7wwLYAo
pEVQNyd/XoBxzSIWx7elUpaNfYc6/w8WizAmgrkrNTMzAzDTBh7GKQ9fgkOqJAWVo0/UUnEw9gB8
nCrhwhhtAaoonJaMWvam7M2JauENGo0ojKSm45D4UHocBHstaZIF+AZYO/N61bUHwx8YXGXqaNC1
RzBN9eLFLtOypWvFC9c24HNzb4Kp3NslW3uPwzd7E3/0sgTP994aPLlEJ+qeFbgvyd4FrHx19/Dg
tXVt0f2pTm+Vje8Wh/JtXnNsXCsWKQ//KfM2dZa59d3iYH7KY1l/klJNwY38heIVtjny7Xxx8+SO
Q/Y6LJpkz0bx/RIkvnDrHVduOPbirmxe8Kw3m1jLhbfpr8bq0nUqDqc6mr3gZz+kI/GNQIQDlZsp
QHQSsj4z0sjt7f0kbzv4cuyAaBnMvqcUiC4Rl7Bfd1gvjFUrjeKTiZVGqQEqnV2/vhJ3ULQMgejU
uRq/X4ZA3OVALUMgUMsQCNQyBAKBWoaIEnIH5vSVDuTJnhVqGQLRatgPQ8nE+u0MBdVeUpNG1r79
rT+Wiarg3iS68hPbAxsfsiuVjUbLtPYT4xaJwYR6sTHYiBtWnoyvORBRa9m+Qbz0zt5Xia5E3iS6
Jsge/dvr3tRchyJ7kOgh7ULsdHW5Yf9RyRCt1DJt1Gd9TeuKxAyqo7xsTjjqdGBOE+xONumNnq+F
jclBBtJ4NqxhhRXmiiD7GwDM3GRATToIC7NOzMlPy6xR35gQrKCmbq4Ic94guvnm6LzEZkwac5W3
rsheT2RLUT0SOZPUy9f2SM3LUrIG3OBUFtRiabZDH+ic7PraF0yPHWUTuZHIiaepRZzXRnUhrnWZ
WRypKw9zfUUarBfd+TbiRp2iZZzpEC2Yy4jRY2V/xZNbNs/K4fcdSJDoUPkS780cBCKydRnx778h
1kkeXbUpG82RyJtWbsqmqWOKytg9EC3UMmi4oS97L4mIbeFjD3rpAwmtA65EdRSyuakHJ6y2COtg
52TPqq/RykjdAbEWL1pQW7G4Fjm2O9v+uscaq35hdtW0PdCLq9U8I+O6++1WNhbnQPwMR5NhLR3q
X+NR2P4mMrz9QJpK6ZlXFA21L5YayqMp/zI/y45E14zR0e1j2Yfw6JEE3NvPzfTKKBojqhbdD0uN
5RH6hJVMcSeULPjELLdEeREtlWIHNsN+WPJJG/rsB4mAIloLuYntSNS0ti9f5M5rhX2wRCBaLUMg
ItLTTpvPWscSahniDk9Csn6e9eDNz6hliE7pjHehuY7+ZYg2zYh3EUu2nXzZc6gx3n+Fe5FMak7x
ul8+2Y7Few1wMrHFkmj8yRBR9sn9vy9rMmULjNgIWArxvkwm9VKTsEXKpJHWQU28u8KkJrX1vlsO
4U+GaoboSItRlmXzIuunh2XjsaxPPnosuGL0tM68aIw90shXrq9kAQ5TIRDdgj7vuc/lWuxyNQPn
G/JaJzRXXsThhcb+2728ak3HBkoWyJ/MsdhGLUV0npbZe6jPM6cvGQls0HoqTghl8PEn6+Q1NgIt
RpvFSNzGX4PObFF6Woz1Ipu2CAmFP5GMs1j3Q7L9doZaX2pk5fXVn2mCvwonTgux7qwVwn0soA42
tBhRx9oF9hG0aL4Q8evsWxNvdN23rliaeeDy9msxBt2bI3KNU6UM/lsZ7qVb00oR7i/1IO4UovsG
S5llNjXjvG9pscHL24fFSLRT9/rF1BriOIxvv7OF3VaaI5GVsZavtuHITvnLPssqK5+6R/B1Etld
AVS2tiEdF4QUPKiA8iBIopCQtOlG/Vj1YBxmeT6e1qwy8cFU1owbEXmaCrIkzqfovfFvNsHHh/Rw
PA9KHJQk1694FDsrcnFi0SQVq1gSh5TAi9qH+JSk8IRVrJa/NiWGKy+slhFj1WNdiLnLoN9bSyMz
hS2GEH0ThNjJiD0HMPI10nqtsqxSHcU1msEsLhwVQLQNm8+V1x+C3BvgDfPwVLwc/wkrqvcmnOuv
PLfJbp6SvrBmRf1qspIs0uvezf4inUdm2OwyA+/5ZoVqh3bP34LnBRh+VVkZ9ij2PZKS2DJonlZ4
O81N2ExUJK1f9AnLD9tSsfyN2SxMec3tfnQ20J+sGxZm7PvU22dBLMDlCigcPLMIhUmLoJACrvzE
vdqHdp8ppXasqE+tgpSh16UUuxgonQXZuP/3X4BnOCgPg1j2KLYkqhlcZjTbJ2HR9jXfRVqsUipp
T4RC6jve+Qct7+BqGZAWUiMiWpfNqFOAMqR+Xv7eHdhdhWoKUrMWATUJ1+GRI8uaiUf7vhWlpWIk
duQH++OmBrwPPr8KGapUVY9ipcEqpbyX0UzTYmOOYv92b+iIZvfFUjDhnX/Q8g6wliG6BYN7z96i
PZsb+mOAnASS1t2NvXGu+Nrlo1onlEBf76hxg9XVfo/M7o/xt01l+dwgNe5yVKm8Pnj9xtjwC5Rm
YKikFVt1FDuxtZz4iFFa3irWnn+48lDLEG3Eb6zdq65juJMfA/iECOOfoD01JY3qsY/OpjJ72lQx
Diodr8XtrJZsdtk40445Capcoc+8J/fReVFYA5LwKHbvnwvn6eX/nKQz1/Y/whidkuZmzWLFUir2
ZywUHwOVTo/T89cQqjzUMkQbMXXoiNq/Xs8VaHiY354CSBYP9+qxX3y3MLjBQt8p8+o0l9fiNg69
19Yr//yw+vvDhyF56vDnzftvzb0VYO3N/HbSo9jkBw+rGXxrdpGq7IN8ZY3mee6IUWzyl7iiVuyq
wqt0G1kWp+evIVR5/ojhugXREfslMwe4WNQyREeArxzgYtFiRHQEKge5WNQyBAK1DIFALUMgEKhl
CARqGQKBWoZAIFDLEAjUMgTibsb/B8g/okzkiayXAAAAAElFTkSuQmCC
</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2014-10-21 11:30:27 +1000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2010-05-06 17:49:12 +1000" MODIFIED_BY="[Empty name]">Previous searches</TITLE>
<APPENDIX_BODY MODIFIED="2014-10-03 19:02:57 +1000" MODIFIED_BY="[Empty name]">
<P>For the last update we searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2011, Issue 2), (accessed 23 June 2011), MEDLINE (December 2007 to June Week 4, 2011), EMBASE (December 2007 to June 2011) and LILACS (2007 to June 2011).</P>
<P>Previously we searched the Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I> 2007, Issue 4), which contains the Acute Respiratory Infections Group's Specialised Register; MEDLINE (1966 to December 2007); EMBASE (1974 to December 2007); and LILACS (1982 to December 2007).</P>
<P>We used the following MeSH and free-text terms to search MEDLINE and CENTRAL. The MEDLINE terms were combined with the Cochrane highly sensitive search strategy phases one and two as published in Appendix 5b of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (Higgins 2005). These terms were modified to search EMBASE and LILACS as required.</P>
<SUBSECTION>
<HEADING LEVEL="4">MEDLINE (PubMed)</HEADING>
<P>#1 Pneumonia OR pneumonias OR pneumoniae<BR/>#2 Lung Inflammation OR Pulmonary Inflammation<BR/>#3 Pneumonitis OR pneumonitides<BR/>#4 Respiratory Tract Infection OR Respiratory Infection<BR/>#5 Tracheobronchitis OR Tracheobronchial<BR/>#6 OR/1-5<BR/>#7 Mechanical Ventilator OR Mechanical Ventilation OR Pulmonary Ventilator<BR/>#8 Respirator* OR Ventilator* OR Ventilation<BR/>#9 Artificial Respiration<BR/>#10 OR/7-9<BR/>#11 Culture Media<BR/>#12 Microbiology OR Bacteriology<BR/>#13 Bronchoscopy OR Bronchoscop* OR Bronchoalveolar Lavage OR Bronchioalveolar Lavage OR Bronchopulmonary Lavage OR Lung Lavage OR Bronchial Lavage OR Alveolar Lavage<BR/>#14 Endotracheal aspirate OR Tracheal aspirate<BR/>#15 Protected brush<BR/>#16 Invasive OR Noninvasive<BR/>#17 Qualitative OR Quantitative<BR/>#18 OR/11-17<BR/>#19 #6 AND #10 AND #18</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2014-10-21 11:30:27 +1000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2014-10-21 11:30:14 +1000" MODIFIED_BY="[Empty name]">MEDLINE (Ovid) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-10-21 11:30:18 +1000" MODIFIED_BY="[Empty name]">
<P>
<B>MEDLINE (Ovid)</B>
</P>
<P>1 exp Pneumonia/<BR/>2 pneumon*.tw.<BR/>3 ((lung or pulmonary) adj3 (inflam* or infect*)).tw.<BR/>4 exp Respiratory Tract Infections/<BR/>5 (respiratory adj3 infection*).tw.<BR/>6 tracheobronch*.tw.<BR/>7 or/1-6<BR/>8 exp Ventilators, Mechanical/<BR/>9 Respiration, Artificial/<BR/>10 (respirat* or ventilat*).tw.<BR/>11 or/8-10<BR/>12 7 and 11<BR/>13 Pneumonia, Ventilator-Associated/<BR/>14 vap.tw.<BR/>15 or/12-14 (66503)<BR/>16 exp Culture Media/<BR/>17 culture media.tw.<BR/>18 microbiology/ or bacteriology/<BR/>19 (microbiol* or bacteriol*).tw.<BR/>20 (invasive or non-invasive or noninvasive or non invasive).tw.<BR/>21 ((qualitative or quantiative) adj3 (culture* or method* or technique* or analys* or assess*)).tw.<BR/>22 Bronchoscopy/<BR/>23 bronchoscop*.tw.<BR/>24 exp Bronchoalveolar Lavage/<BR/>25 (lavage adj2 (bronchoalveolar or bronchioalveolar or bronchial or lung or alveolar or bronchopulmonary)).tw.<BR/>26 BAL.tw.<BR/>27 (aspirat* adj2 (endotracheal or tracheal)).tw.<BR/>28 (protected brush or protected specimen brush or protected-specimen brush).tw.<BR/>29 (non-bronchoscopic or nonbronchoscopic or non bronchoscopic).tw.<BR/>30 mini-BAL.tw.<BR/>31 ((psb or bbs or bpsb) adj5 (sampl* or techniq* or method*)).tw.<BR/>32 or/16-31<BR/>33 15 and 32</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2014-10-21 11:30:27 +1000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2014-10-03 19:02:07 +1000" MODIFIED_BY="[Empty name]">EMBASE (Elsevier) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2011-10-10 10:54:48 +1000" MODIFIED_BY="[Empty name]">
<P>35. #31 AND #34<BR/>34. #32 OR #33<BR/>33. random*:ab,ti OR placebo*:ab,ti OR factorial*:ab,ti OR crossover*:ab,ti OR 'cross-over':ab,ti OR 'cross over':ab,ti OR volunteer*:ab,ti OR allocat*:ab,ti OR assign*:ab,ti OR ((singl* OR doubl*) NEAR/2 (blind* OR mask*)):ab,ti<BR/>32. 'randomised controlled trial'/exp OR 'single blind procedure'/exp OR 'double blind procedure'/exp OR 'crossover procedure'/exp<BR/>31. #14 AND #30<BR/>30. #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29<BR/>29. ((psb OR bbs OR bpsb) NEAR/5 (sampl* OR techniq* OR method*)):ab,ti<BR/>28. 'mini-bal':ab,ti<BR/>27. 'non-bronchoscopic':ab,ti OR 'non bronchoscopic':ab,ti OR nonbronchoscopic:ab,ti<BR/>26. 'protected brush':ab,ti OR 'protected specimen brush':ab,ti OR 'protected-specimen brush':ab,ti<BR/>25. (aspirat* NEAR/2 (endotracheal OR tracheal)):ab,ti<BR/>24. bal:ab,ti<BR/>23. (lavage NEAR/2 (lung OR bronchoalveolar OR bronchialalveolar OR bronchial OR alveolar OR<BR/>bronchopulmonary)):ab,ti<BR/>22. 'lung lavage'/de<BR/>21. bronchoscop*:ab,ti<BR/>20. 'bronchoscopy'/exp<BR/>19. ((qualitative OR quantitative) NEAR/3 (culture* OR method* OR technique* OR analys*)):ab,ti<BR/>18. invasive:ab,ti OR 'non invasive':ab,ti OR 'non-invasive':ab,ti OR noninvasive:ab,ti<BR/>17. 'culture media':ab,ti OR 'culture medium':ab,ti OR microbiol*:ab,ti OR bacteriol*:ab,ti<BR/>16. 'microbiology'/de OR 'bacteriology'/de<BR/>15. 'culture medium'/exp<BR/>14. #11 OR #12 OR #13<BR/>13. vap:ab,ti<BR/>12. 'ventilator associated pneumonia'/exp<BR/>11. #7 AND #10<BR/>10. #8 OR #9<BR/>9. respirat*:ab,ti OR ventilat*:ab,ti<BR/>8. 'artificial ventilation'/exp<BR/>7. #1 OR #2 OR #3 OR #4 OR #5 OR #6<BR/>6. tracheobronch*:ab,ti<BR/>5. (respiratory NEAR/3 infection*):ab,ti<BR/>4. 'respiratory tract infection'/exp<BR/>3. ((lung OR pulmonary) NEAR/3 (inflam* OR infect*)):ab,ti<BR/>2. pneumon*:ab,ti<BR/>1. 'pneumonia'/exp</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2014-10-21 11:30:24 +1000" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2013-06-25 13:16:18 +1000" MODIFIED_BY="[Empty name]">LILACS (BIREME) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2013-06-25 13:17:18 +1000" MODIFIED_BY="[Empty name]">
<P>(((mh:pneumonia OR pneumon* OR neumonía OR mh:c08.381.677* OR mh:c08.730.610* OR pulmonía OR mh:"Respiratory Tract Infections" OR mh:c01.539.739* OR mh:c08.730* OR "Infecciones de las Vías Respiratorias" OR "Infecciones del Aparato Respiratorio" OR "Infecciones del Tracto Respiratorio" OR "Infecciones Respiratorias" OR "Infecções das Vias Respiratórias" OR "Infecções do Aparelho Respiratório" OR "Infecções do Sistema Respiratório" OR "Infecções do Trato Respiratório" OR "Infecciones del Sistema Respiratorio" OR "Infecções Respiratórias" OR tracheobronch*) AND (mh:"Ventilators, Mechanical" OR "Ventiladores Mecánicos" OR "Ventiladores Mecânicos" OR mh:e07.950* OR mh:"Respiration, Artificial" OR "Respiración Artificial" OR "Respiração Artificial" OR "Ventilación Mecánica" OR "Ventilação Mecânica" OR respirat* OR ventilat*)) OR (mh:"Pneumonia, Ventilator-Associated" OR vap OR "Neumonía del Ventilador" OR "Pneumonia Associada ao Ventilador" OR "Pneumonia Associada ao uso de Ventiladores Pulmonares" OR "Pneumonia Associada ao uso de Ventiladores Artificiais" OR "Pneumonia Associada a Respirador" OR "Pneumonia Associada a Respirador Mecânico")) AND (mh:"Culture Media" OR "Medios de Cultivo" OR "Meios de Cultura" OR mh:d27.720.470.305* OR mh:e07.206* OR "culture media" OR mh:microbiology OR microbiol* OR mh:bacteriology OR bacteriol* OR invasive OR "non-invasive" OR noninvasive OR "non invasive" OR qualitative OR quantiative OR mh:bronchoscopy OR broncoscop* OR mh:"Bronchoalveolar Lavage" OR "Lavado Broncoalveolar" OR "Lavagem Broncoalveolar" OR "Bronchial Lavage" OR "Lung Lavage" OR mh:e05.927.100* OR "Lavado Bronquial" OR "Lavado Pulmonar" OR "Lavagem Bronquial" OR "Lavagem Pulmonar" OR bal OR "protected brush" OR "protected specimen brush" OR "protected-specimen brush" OR "non-bronchoscopic" OR nonbronchoscopic OR "non bronchoscopic" OR "mini-bal" OR psb OR bbs OR bpsb) AND db:("LILACS") AND type_of_study:("clinical_trials") AND year_cluster:("2011" OR "2012" OR "2013")</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>